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The majority of acute cerebral infarcts results from an occlusion of one single cerebral 
artery followed by loss of blood supply to the respective arterial territory. However, 
several independent arterial territories may be affected if more than one cerebral artery 
is occluded simultaneously. Acute cerebral infarcts in multiple arterial territories 
(MACI) account for 10 to 20 % of all ischemic strokes. MACI may have distinct 
pathophysiological and clinical features differing from acute cerebral infarct(s) in a 
single arterial territory (SACI).  
Aims 
In this dissertation, we sought to give a broad description of patients with MACI. The 
aim of the first two papers was to clarify pathophysiological mechanisms in regards to 
the etiology. In the third paper, we assessed short-term outcome and complications 
within the first week after the hospital admission. The fourth paper sheds light on the 
clinical manifestation on admission. 
Methods 
We used data from the Bergen NORSTROKE registry. We included only patients with 
acute cerebral infarct(s) (ACI) confirmed by diffusion-weighted magnetic resonance 
imaging (DWI-MRI) consecutively admitted to the stroke unit at Haukeland 
University Hospital. The first two papers are based on a cohort of 2125 patients 
admitted from 2006 to 2013. The last two papers are based on a cohort of 3343 
patients admitted in an extended time frame from 2006 to 2016. MACI was defined as 
more than one non-continuous ischemic lesion in more than one arterial cerebral 
territory; either left and/or right carotid artery territory and/or basilar artery territory.  
Results 
The proportion of patients with MACI was approximately 9% of all ACI patients. The 
paper-I confirmed that cardiogenic embolism (CE), as defined by TOAST criteria, is 
the most frequent underlying etiology of MACI. The paper-II showed a positive 
correlation between the time from stroke onset to MRI examination and frequency of 
large artery atherosclerosis (LAA)-associated MACI. There was no correlation 
between the time from stroke onset to MRI examination and frequency of CE-




associated MACI. These findings suggest that CE-associated MACI occur 
simultaneously as a shower of emboli, while LAA-associated MACI happens rather 
successively over time. The paper-III showed that patients with MACI have a worse 
short-term outcome within the first week after the admission compared to patients with 
SACI. Moreover, MACI was associated with more in-hospital complications, namely 
deep venous thrombosis and myocardial infarction. The paper-IV showed that 72% of 
patients diagnosed with MACI presented with a single-territory clinical manifestation 
(MACI-S) on admission. MACI-S was associated with less than five ischemic lesions 
on DWI-MRI, involvement of the left hemisphere, and a partial anterior cerebral 
infarct stroke syndrome (PACI) as defined by the Oxfordshire Community Stroke 
Project (OCSP) classification. This finding emphasizes the essential role of MRI 
examination for final diagnosis of MACI.  
Conclusion 
The data presented in this dissertation show that patients with MACI differ in many 
clinical aspects from patients with SACI. Our findings add new knowledge to this less 
documented field of stroke medicine and may help to improve the diagnostic and 
therapeutic approaches in these patients.  
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Cerebral infarct (CI) / Ischemic stroke represent the major category of stroke. CI is a 
focal brain injury due to acute disruption of nutrition and oxygen supply to the brain 
tissue. This is followed by a corresponding neurological deficit or death. 
The latest consensus on CI definition follows the advances in medical technology 
achieved in the past decades. Previously, the definitions were based solely on the 
clinical manifestation, not reflecting the tissue-based verification of the CI. This 
resembles the former World Health Organization (WHO) definition from 1980: 
”Rapidly developing clinical signs of focal (or global) disturbance of cerebral function, 
lasting more than 24 hours or leading to death, with no apparent cause other than that 
of vascular origin.”1  
However, the additional implementation of modern neuroimaging changed the concept 
of CI diagnosis. The definition of CI also incorporates a silent CI, characterized by no 
clinical symptoms, yet by a focal brain injury identified by neuroimaging.2 A more 
precise definition of central nervous system infarct endorsed by American Stroke 
Association (ASA) from 2013 is: “Brain, spinal cord, or retinal cell death attributable 
to ischemia, based on neuropathological, neuroimaging, and/or clinical evidence of 
permanent injury.”3 This change has an implication for the stroke epidemiology 
worldwide since the prevalence of silent CI ranges from 10% to 20% among patients 
over 70 years.4 The unavailability of MRI in less developed countries may, however, 
potentially underestimate the true rates.  
The introduction of diffusion-weighted magnetic resonance imaging (DWI-MRI) in 
the routine diagnostic work-up of stroke also led to a tissue-based redefinition of 
transient ischemic attack (TIA). Several studies have shown that up to 50% of patients 
diagnosed with TIA based on the clinical, time-based definition, have evidence of 
focal brain injury on MRI. These findings left behind the arbitrary 24 hours period as 
obsolete. The assumption that transient neurological deficit could not be accompanied 
by irreversible brain injury is not valid anymore. The new definition endorsed by ASA 




is: “A transient episode of neurological dysfunction caused by focal brain, spinal cord 
or retinal ischemia, without acute infarction”.5  
 
Epidemiology & burden of stroke 
A significant improvement in stroke therapy and prevention has been achieved in most 
of the developed countries. However, comparing the years 1990 and 2010, stroke 
remains the second most frequent cause of mortality after ischemic heart disease. 
Moreover, stroke moved from the 5th to the 3rd most common cause of disability 
worldwide.6 These epidemiological data reflect both regional and ethnic differences, 
but also the availability of healthcare resources and public stroke awareness. All of 
these factors have an impact on morbidity, mortality, etiology of stroke and their 
trends over time. 
In 2016, there were 13.7 million new stroke cases worldwide, with a reduction of age-
standardized incidence by 8.1% from the year 1990. Furthermore, there was a clear 
reduction in global age-standardized mortality rate and disability-adjusted life years 
(DALYs) by 34.2% and 36.2%, respectively.7 The relative numbers have satisfying 
progression, however the absolute numbers are moving the opposite direction, mostly 
due to rapid population growth and ageing. Furthermore, there are significant regional 
differences. While the incidence of stroke is decreasing in high-income countries; the 
incidence, mortality and DALYs in many low- and middle-income countries are 
increasing. This phenomenon reflects the so-called epidemiological transition of 
developing countries caused by an increase in modifiable risk factors, which so far 
were reduced effectively in the developed countries.  
Thus, despite relatively positive progression in high income-countries, the global 
burden of stroke is increasing, and further research within the field of implementing 
and improving primary prevention worldwide is crucial.  
According to the national Norwegian and American reports, 87% of strokes are 
ischemic, and 13% are hemorrhagic.8, 9 Globally, the rate of intracerebral hemorrhage 
(ICH) is higher than in the Caucasian population alone. This reflects a higher 
incidence of ICH in Asia, low- and middle-income countries where hypertension as 




the critical factor in the pathogenesis is more prevalent.10 Lower rates of ICH in the 
high-income countries reflect the effective prevention of modifiable risk factors, 
including hypertension. There are still huge gaps between regions regarding the 
prevention of modifiable risk factors, screening for conditions increasing risk of stroke 
such as diabetes mellitus (DM), atrial fibrillation (AF) or hypertension and availability 
of appropriate secondary prevention for recurrent stroke.   
 
Pathophysiology 
Cerebral blood flow and the penumbra concept 
Around 20% of the cardiac output is directed to the brain, although the brain 
represents only 2% of the total body weight. In contrast to other organs of the human 
body, the brain tissue keeps only a very low amount or no reserves of nutrition and 
oxygen, which may be utilized in case of acute ischemia. The brain is, therefore, 
completely dependent on continuous blood supply. The primary defense mechanism 
against misbalance in cerebral blood flow (CBF) is cerebral autoregulation. It 
maintains a constant level of CBF via constriction or dilatation of cerebral blood 
vessels in response to, among others, variations in mean arterial pressure. However, 
the cerebral autoregulation is only effective in the range of mean arterial pressure from 
approximately 60 to 150 mmHg. Outside these thresholds, the compensatory capability 
of autoregulation collapses. (Figure 1) In ACI, the cerebral perfusion pressure within 
the affected area falls, followed by the compensatory response. However, an 
immediate lack of oxygen and glucose in the core of ischemia is unavoidable. If 
perfusion is not restored soon enough, irreversible ischemia-induced brain tissue 










Figure 1. Autoregulation of cerebral blood flow 
  
Adapted from Pires et al., 2013 
 
Perfusion imaging techniques based on computed tomography (CT) or magnetic 
resonance imaging (MRI) are able to measure the amount of blood passing through a 
defined area of brain tissue at a certain time - absolute CBF. An essential feature of 
perfusion techniques is the capability of measuring the relative CBF, thus distinguish 
salvageable brain tissue (penumbra) from an infarct core. The differentiation between 
salvageable brain tissue at risk and infarcted tissue irreversibly lost due to ischemia is 
nowadays utilized in acute reperfusion therapies. 
The average values for CBF in the healthy brain are 50 +/- 15 ml/ 100 g / min for grey 
matter and 22 +/- 5 ml /100 g/ min for the white matter. If the CBF falls below these 
levels, the cerebral tissue enters the stage of ischemic risk (penumbra). The critical 
average threshold of CBF for penumbra based on CT/MRI perfusion imaging has been 
reported from 14 to 35 ml/100 g of brain tissue. CBF values under 4.8 to 8.4 ml/100 g 
defines an infarct core, where the neuronal electrical activity ceases, and the brain 
tissue is irreversibly damaged despite reperfusion therapy.11  




The CBF is also secured by an extensive collateral blood circulation (CBC) preserving 
blood supply in case of cerebral artery occlusion. The primary CBC route is secured 
by the circle of Willis, connecting the left and right anterior and posterior circulations 
via corresponding communicating arteries. The secondary CBC routes are far more 
complex, comprising connections between the internal and external carotid artery but 
also deep connections between a middle cerebral artery (MCA), posterior cerebral 
artery (PCA) and anterior cerebral artery (ACA).  Perforator and leptomeningeal 
collateral systems play a crucial role when occlusion of an intracranial artery occurs. 
In addition, branches of the external carotid artery, such as ophthalmic, meningeal and 
occipital arteries, are recruited in case of internal carotid artery (ICA) occlusion.12  
However, human cerebral vasculature varies from person to person. The state and 
functionality of CBC and cerebral autoregulation determine the progress of cerebral 
ischemia as such. The transformation time of reversible penumbra into an irreversible 
infarct core is largely individual and relies strongly on the unique capability of the 
brain to compensate the ischemia.13 Today, the efficacy of acute reperfusion therapy 
by either intravenous thrombolysis (IVT) or mechanical thrombectomy (MT) is based 
on the concept that the process of developing ACI is gradual, and the infarct core 
expands in time. The main goal of reperfusion therapies is to save the salvageable 
brain tissue, represented by the area of benign oligemia and penumbra surrounding the 
gradually expanding infarct core. This also supports the concept of individual time 
window-based acute reperfusion therapy. The current arbitrary time-window of 4.5 
hours for IVT14 and previous time-window of 6 hours for MT may exclude patients 
whose individual time window is wider due to great collateralizations, and who still 
benefit from reperfusion therapies beyond the formal time windows. The tissue-based 
patient selection to acute reperfusion therapy by MT using advanced CT and MRI 
techniques was recently proven successful.15, 16 Advanced imaging techniques will 
likely increasingly become an essential part of acute stroke diagnostics and therapy. 
 




Mechanism of arterial occlusion 
Cerebral ischemia evolves after either sudden or gradual occlusion of a cerebral artery. 
The occlusive process usually occurs by either embolism or thrombosis, both leading 
to hyporfusion.17   
Embolism  
Embolism is a broad term comprising all ischemic events where the occlusion is 
caused by a blood clot or other debris originating proximally from the site of the 
occlusion. The most common sources of the embolic stroke are cardiogenic embolism 
(CE) and artery-to-artery embolism from aorta, from carotid or vertebral arteries, or 
from intracranial arteries. Several clinical characteristics may indicate an embolic 
stroke. The symptomatology depends on the size, number of emboli and time pattern 
of embolization. However, the onset of neurological deficit is often sudden, with 
maximal severity at the beginning of the stroke.18 Symptoms may fluctuate in intensity 
as the emboli dissolves or fragmentizes and passes to the distal vessels of smaller 
calibers. Both simultaneous and successive involvement of multiple arterial territories 
is characteristic for embolism as the source of emboli often lies proximally to aortic 
arch.19 The embolic stroke tends to affect distal parts of the cerebral arterial tree, often 
appearing as cortical lesions rather than lesions in deeper structures of the brain. 
Embolic stroke also has a higher tendency of hemorrhagic transformation as a 
consequence of acute vessel wall damage and disruption. The etiologies of CE are 
divided into two categories based on the degree of risk for embolism (Table 1).  
 
  




Table 1. Cardiogenic and aortic sources of embolism  
High primary stroke risk   Low or uncertain primary stroke risk  
Chronic atrial fibrillation Cardiac sources  
Paroxysmal atrial fibrillation Mitral annular calcification 
Left atrial thrombus Patent foramen ovale 
Left ventricular thrombus Atrial septal aneurysm 
Sick sinus syndrome Atrial septal aneurysm and patent foramen ovale 
Atrial flutter Left ventricular aneurysm without thrombus 
Recent myocardial infarction (within one month) Left atrial spontaneous echo contrast ("smoke") 
Mitral stenosis or rheumatic valve disease Congestive heart failure, ejection fraction <30% 
Bioprosthetic and mechanical heart valves Apical akinesia 
Chronic myocardial infarction with low ejection 
fraction (<28 %) 
Wall motion abnormalities (hypokinesia, 
akinesia, dyskinesia) other than apical akinesia 
Dilated cardiomyopathy (left ventricular 
dilatation with ejection fraction <40% or 
fractional shortening <25%) 
Hypertrophic cardiomyopathy 
Non-bacterial thrombotic endocarditis Left ventricular hypertrophy 
Infective endocarditis Left ventricular hypertrabeculation/ 
non-compaction cardiomyopathy 
Papillary fibroelastoma Aortic sources  
Left atrial myxoma Complex aortic atheroma (protruding >4 mm, or 
mobile debris, or plaque ulceration) 
Adapted from Ay H et al. Ann Neurol 2005 
 
Thrombosis 
In contrast to embolism, thrombosis refers to an occlusion occurring on the site of a 
pathological process in the wall of the affected vessel, such as on top of preexisting 
atherosclerosis or as a result of arterial dissection. However, both atherosclerotic 
plaque and arterial dissection may also become a source of distal embolization. The 
onset of the neurological deficit is often gradual since the occlusion of the affected 
artery often evolves over time.  
Based on the caliber of the affected arteries, two main pathomechanisms are 
distinguished - small vessel disease (SVD) and large vessel disease (LVD). Large 
vessel disease mostly refers to large artery atherosclerosis (LAA) within either 
extracranial or intracranial arteries of a bigger caliber. The terms LVD and LAA are 
often used interchangeably in relation to the TOAST classification. SVD primarily 
affects the penetrating arteries arising from the circle of Willis, and from the MCA and 
the basilar artery (BA) supplying subcortical structures of the brain. SVD is 
responsible for approximately 25% of all CI. SVD is also one of the most common 




causes of dementia. The prevalence of SVD grows rapidly with age reaching almost 
100% in patients over 90 years old20, but varies largely in degree. The 
pathophysiology of SVD is not entirely understood. However, hypertension, DM, and 
ageing play an essential role in the pathogenesis. The arterial walls undergo 
pathological processes including lipohyalinosis and formation of microatheromas and 
microaneurisms.21 SVD appears as disseminated white hyperintensities (leukoaraiosis) 
on fluid-attenuated inversion recovery (FLAIR) MRI. Critical ischemia then manifests 
as small ischemic lesions appearing as small lacunes. Simultaneous multiple-territory 
distribution of lacunar stroke is, however, rare as occlusions probably occur 
independently of each other.22 
Hypoperfusion 
Conditions such as myocardial infarction (MI), pulmonary embolism, severe 
arrhythmia or cardiac arrest are often accompanied by a reduced or complete failure of 
cardiac output. Systemic hypoperfusion may lead to an acute reduction of cerebral 
blood flow followed by cerebral ischemia. ICA stenosis may further aggravate its 
progress. Hypoperfusion-associated (watershed) stroke usually appears as non-focally 
distributed lesions along the border-zone of two or three main cerebral arteries.23 
Prothrombotic blood disorders 
Prothrombotic blood disorders are often discussed as a separate pathophysiological 
entity since both embolism and thrombosis may co-exist. In young stroke patients and 
patients with so-called cryptogenic stroke, disturbances in blood coagulation should 
always be taken into consideration. There are many systemic and blood disorders that 
may promote clot formation and subsequent stroke. A tendency to the hypercoagulable 
state may be inherited, such as in Factor V Leiden or protein C or S deficiency. 
However, some inflammatory diseases and malignancies may cause an acquired 




Cerebral infarct (CI) is a heterogeneous disorder that may be caused by over 200 so far 
known etiologies. There have been proposed several classification systems for CI. The 




main purpose is to establish a simple and reproducible clinical tool in daily practice 
and research. An ideal classification system should be capable of determining the most 
probable cause and mechanism for the best therapeutic decision-making.  
There are two types of classification systems, either causative or phenotypic. The 
causative system determines the most probable etiology, yet neglecting other 
competing and less probable etiologies. The phenotypic classification, on the other 
hand, stratifies alternative etiologies by a degree of probability.25  
When evaluating the feasibility and quality of a classification system, its reliability 
must be considered. The reliability shows the reproducibility of the findings performed 
by either the same (intra-rater reliability) or two different observers (inter-rater 
reliability). The reliability is expressed by the kappa coefficient (κ), which shows the 
strengths of agreement between two observers. (Table 2)  
 
Table 2. Observer agreement measure stratification 
Kappa  Degree of agreement  
≤0.00 Disagreement  
0.00-0.20 Slight agreement 
0.21-0.40 Fair agreement 
0.41-0.60 Moderate agreement 
0.61-0.80 Substantial agreement 
0.81-1.00 Almost perfect agreement 
Adapted from JR Landis & GG Koch, 1977 26 
 
The most widely used classification system for CI is the Trial of ORG 10172 in Acute 
Stroke Treatment (TOAST) classification representing the causative classification 
system.17 TOAST is simple to use but has several drawbacks. It neglects competing 
etiologies that are less probable. Furthermore, its reliability is not high. While the 
inter-rater reliability for CE and large artery atherosclerosis (LAA) seems to be quite 
strong (κ ≈ 0.8), it is rather weak for the SVD and stroke of undetermined etiology 
(UE) (κ ≈ 0.53 and κ ≈ 0.4, respectively).27 Based on TOAST criteria, only subcortical 
lesions with less than 15 mm in diameter accompanied by a lacunar clinical syndrome 
are classified as SVD. The strict TOAST criteria, based originally on CT findings, 




have been challenged for inaccuracy and non-reliability. MRI studies showed that 
lacunar infarcts may grow in the acute phase and reach over 20 mm in diameter. In 
patients, where the evaluation of intracranial vessels was not performed sufficiently, 
subcortical lesions caused by LAA may be categorized as SVD.28 Only patients with 
stenosis >50% on the ipsilateral side of the symptomatic lesion are classified as LAA. 
Therefore, CI accompanied by stenosis <50% and subcortical lesions >15 mm are 
classified as UE subtype. This also contributes to the fact that around 40% of all 
patients with CI end up within this category.  
Along with the new neuroimaging techniques, TOAST was later on updated to the 
Stop Stroke Study TOAST system (SSS-TOAST) in order to overcome some of the 
drawbacks. SSS-TOAST assigns to each causative subtype one of three grades of 
evidence, “evident”, “probable” or “possible”. The maximum size for a subcortical 
lesion was increased to 20 mm in order to improve the reliability within the SVD 
category. Furthermore, subcortical lesions of over 20 mm in size may still be classified 
as SVD if no other cause is present. Embolic lesions in patients with ipsilateral 
stenosis <50% with protruding plaque into the vessel lumen are classified as LAA if 
no other evidence is present. SSS-TOAST also proposed a new sub-category of the 
undetermined CI subtype, cryptogenic stroke.29 These thorough changes decreased the 
proportion of undetermined cause from 40% to only 4% and increased the reliability 
within this category to κ=0.8. The SSS-TOAST is, however, quite complicated, thus 
not much used in daily practice. Therefore, a computerized on-line version of SSS-
TOAST with few discrete changes known as The Causative Classification of Stroke 
System (CCS) was introduced in 2007.30 The web-based platform is freely available. It 
provides an overview of the etiologies based on the grade of evidence and is quite easy 
to use.   
The ASCO (Atherosclerosis, Small vessel disease, Cardiac source, Other cause) 
classification represents the first purely phenotypic system.31 The main advantage of 
ASCO over TOAST is the inclusion of all potential causes simultaneously assigning 
corresponding grades of evidence to each of them. This provides a useful overview of 
all potential risk factors. In 2013, an updated version was introduced known as 
Atherosclerosis, Small vessel disease, Cardiac source, Other Cause, Dissection 




(ASCOD), where dissection became a separate category. 32 This version also redefined 
significant stenosis by lowering the stenosis degree from 70% to 50%. (Table 3) 
 
Table 3. Classification systems for ischemic stroke 
 TOAST SSS-TOAST CCS ASCO ASCOD 
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Adapted from Kim et al 2013 & Radu et al 2017.   
LAA - large artery atherosclerosis; CE - cardiogenic embolism; SVD - small vessel disease; OD - 
other disease; UE - undetermined etiology; TOAST - Trial of ORG 10172 in Acute Stroke Treatment; 
SSS-TOAST - Stop Stroke Study TOAST system; CCS - The Causative Classification of Stroke system; 
ASCO - Atherosclerosis, Small vessel disease, Cardiac source, Other Cause; ASCOD - 
Atherosclerosis, Small vessel disease, Cardiac source, Other Cause. Dissection; ICA - internal carotid 
artery 
 
Acute cerebral infarcts in multiple arterial territories (MACI) 
Patients with MACI represent a subgroup of patients with distinct epidemiological and 
clinical features. Compared to acute cerebral infarct(s) in a single arterial territory 
(SACI), MACI may give rise to an unusual clinical picture and have a different 
etiological spectrum.33 Thus, the diagnostic work-up and the choice of secondary 
prevention may require a different approach. There have been published several 
studies aiming at MACI. However, different methodologies and different definitions of 
MACI have led to contradictory conclusions. Therefore, many epidemiological and 
clinical aspects remain unclear. 
 
Definition 
There is no established definition of MACI used by the stroke society. The cerebral 
circulation is complex, and every clinician may have a different point of view. 
However, for simplicity reasons and reliability of the data, a reasonable definition 
classifies MACI related to the three main arterial territories. There are two anterior 
territories supplied by the left and right ICA arising from the left and right CCA, 
respectively. The one posterior territory is supplied by the basilar artery arising from 
the confluence of the left and right vertebral arteries.34 ACI must be distributed in at 




least two out of the three arterial territories to be defined as MACI. Figure 2 shows 
four possible topographical distributions of MACI as seen on DWI-MRI.  
 
Figure 2. The combinations of affected arterial territories based on the MACI 
definition used in the dissertation 
 
A–multiple acute cerebral infarcts distributed in both anterior territories; B-multiple acute cerebral 
infarcts distributed in the right anterior territory and in the posterior territory; C-multiple acute 
cerebral infarcts distributed in the left anterior territory and in the posterior territory; D-multiple 
acute cerebral infarcts distributed in all three territories 
 
Epidemiology  
The frequencies of MACI differ between studies and range between 4% and 24%. An 
overview of studies using MACI as defined in this dissertation is shown in table 4. 
Slightly different population characteristics and applied methodologies may have had 
an impact on the final results.  
Altieri et al. and Baird et al. reported low frequencies of 5.6% and 3.4%, 
respectively.35, 36 These studies may be difficult to interpret since the sample sizes 
were small and therefore barely representative for the general stroke population. 




Another five studies comprising bigger sample sizes showed frequencies in the range 
of 9.7 % - 14.5 %.33, 37-40 Three studies of Asian origin reported frequencies between 
9.4 - 16%. 41-43 This indicates that the rate among Asians may be similar to the rate 
among Caucasians.     
The stroke group at Charité – Universitätsmedizin Berlin published two studies 
reporting significantly higher frequencies of MACI (17% and 24%) among 
consecutively admitted patients with CI.44, 45 In contrast to other studies, they used 
3.0T MRI, which is probably more sensitive to reveal ischemic micro-lesions, 
normally not visible on 1.5T MRI. The only study aiming at MACI in young stroke 
patients (age 15-49 years) reported a frequency of 7.5% using a 1.5T MRI.46 
A simple literature-based pooled analysis comprising 21 studies was recently 
published.47 In total, 15056 patients with ACI were enrolled, of which 1914 patients 
(13%) had MACI. The studies included in the analysis were, however, not specified, 
and the inclusion criteria slightly differed from those used in this dissertation. 




















Table 4. The frequencies of MACI in selected studies  
MACI - acute cerebral infarct(s) in multiple arterial territories; * Only young patients (15-49 years); 
** Pooled analysis of 21 studies 
 
The importance of cerebrovascular anatomy 
In patients with acute cerebral infarct (ACI), the knowledge of vascular and functional 
brain anatomy is crucial to make a correct diagnosis and initiate acute reperfusion 
treatment. CI may affect every part of the brain, and the clinical manifestation may 
therefore be very diverse. In patients with SACI, the neurological deficit usually 
corresponds to the affected area of the brain. However, patients with MACI may 
present with unusual clinical manifestation if several independent arterial territories 
are affected simultaneously.  
The blood supply to the brain is maintained by three major arteries, basilar artery (BA) 
and left and right ICA. However, the cerebral circulation is characterised by 
considerable anatomical variations which may have clinical significance in regards to 
MACI definition.48  
The posterior arterial territory supplied by BA comprises the brain stem including 
medulla oblongata, pons and structures of the midbrain, cerebellum and occipital lobes 
of both cerebral hemispheres. The most frequent anatomical variation in the posterior 
arterial territory is a partial or complete fetal PCA (fPCA) occurring in 20-30% of 
individuals.49, 50 fPCA originates from the ipsilateral ICA, and the occipital lobe is then 
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mostly supplied from the anterior circulation. These patients may experience ACI 
distributed in anterior territory and ipsilateral occipital lobe, topographically appearing 
as MACI in both anterior and posterior arterial territory, confusing the MACI 
definition. 
An important anatomical variation in the anterior circulation, which may interfere with 
the MACI definition, is unpaired (azygos) ACA occurring in approx. 2% of 
individuals.51 Left and right ACA or only single ACA arise from one ICA, which 
supplies both ACA territories. In these individuals, bihemispheric ACI affecting both 
ACA territories may occur after embolization from the one supplying ICA. MACI in 
both anterior territories may also be caused by a cross-flow phenomenon where emboli 
pass to the ipsilateral but also to the contralateral anterior territory over the anterior 
communicating artery.52 
Angiographic imaging of the cerebral arterial tree and the examination of cerebral 
hemodynamics by transcranial duplex ultrasound may clarify the true mechanisms of 
such CI.  
 
Etiology  
A definite and correct etiology is paramount to initiate effective secondary prevention 
of recurrent CI. The etiological spectrum of MACI may be different compared to 
SACI. A proximal source of emboli should always be considered in the first line, 
including cardiac disease and aortic arch atherosclerosis.47, 53 However, less common 
etiologies like uncommon cardiac disorders, hypercoagulable states accompanying 
malignancies or immunological disorders require more focus in the etiological work-
up.54-56  
Some studies have shown that embolism from the heart or aorta is the most common 
etiology of MACI.33, 39, 53 High-risk cardiac sources, predominantly paroxysmal or 
chronic AF, should be investigated first.  
Atrial fibrillation 
AF represents one of the most common cardiac arrhythmias and is responsible for up 
to one-third of all cerebral infarcts (CI), frequently distributed in multiple arterial 




territories.44 Thrombogenesis in AF follows the mechanism of Virchow's triad 
comprising hemodynamic changes within the atrium, followed by endothelial 
dysfunction and a hypercoagulable state.57 AF is traditionally categorized as either 
paroxysmal or chronic. Paroxysmal AF is characterized by periods of arrhythmia 
lasting less than seven days with periods of normal sinus rhythm in between. However, 
up to 30% of paroxysmal AF sooner or later transform into the chronic form.58 
Another classification reflects clinical manifestation and categorizes AF as 
symptomatic or silent based on accompanying symptoms such as palpitations or chest 
pain. Patients with AF have a five times higher risk of CI. CI may also be the first 
clinical sign of silent AF.59 AF-related CI is characterized by a higher tendency for 
hemorrhagic transformation, early recurrence and generally less favourable outcome in 
comparison to non-AF related CI.60 The incidence of AF increases with age and is 
expected to increase further due to general ageing of the population. 
In AF-associated MACI, the ischemic lesions show mostly cortical distribution on 
brain imaging.47 Depuyt et al. reported that 49% of MACI were of CE origin of which 
64% caused by AF.33 Patients with MACI on brain imaging with no signs of chronic 
AF on electrocardiography (ECG) should always undergo thorough cardiologic 
examination, including echocardiography and prolonged cardiac monitoring. One-third 
of patients with unknown etiology (UE) of CI have paroxysmal AF. Long-term cardiac 
monitoring with cardiac loop recorder or other available monitoring devices may 
significantly reduce the rate of UE-subtype diagnosis. A score using dichotomized 
variables including age, presence of cardiac diseases and high serum troponin may 
also guide therapeutic decision-making.61   
Aortic embolism 
The presence of aortic atherosclerotic plaques usually reflects the overall 
atherosclerotic profile in the patient. As in carotid atherosclerosis, vascular risk factors 
such as higher age, hypercholesterolemia, hypertension, and smoking are common in 
these patients.62 Aortic plaques associated with a higher risk of embolic CI are referred 
to as complex or unstable. The risk is aggravated by the presence of a mobile 
superimposed thrombus.63 An aortic plaque with thickness over 4 mm increases the 
risk of recurrent CI four times in comparison to those under 1 mm.64 Apart from 




unstable plaque characteristics, and plaque thickness, proximal location in the aortic 
arch is of high importance for cerebral embolization. The prevalence of complex aortic 
atheroma in the general population of elderly Caucasian is approximately 8%, of 
which 0.2% are located in the aortic arch. The prevalence of complex aortic atheroma 
in patients with CI is 14 to 21%, of which 2.2% of those are located in the aortic 
arch.65  
As in other proximal embolic sources, the aortic arch plaque may cause MACI with a 
typical pattern of multiple small cortical lesions. The morphology and configuration of 
the aortic plaque seem to be crucial. The presence of mobile components or plaque 
ulcerations significantly increases the risk of embolization in multiple arterial 
teritorries.53, 66  
Type A aortic dissection (located in ascending aorta) represents another, although less 
common source of aortic emboli. In approximately 6% of all cases, aortic dissection is 
complicated by CI or TIA following an embolization from the aortic dissection itself, 
or due to extension of the dissection into the cervico-cerebral arteries.67 Aortic 
dissection patients require a fast and correct diagnosis to initiate acute surgical 
treatment. Unfortunately, typical related symptoms as chest pain or back pain may be 
masked by concomitant stroke symptoms due to embolization from the site of 
dissection. Alertness with regard to aortic dissection as the underlying cause of stroke 
is mandatory as reperfusion therapy by IVT is contraindicated in these patients. 
After standard diagnostic work-up, the cause remains unknown in more than one third 
of these patients. In patients with MACI, where no cardiac source is found, an aortic 
source of emboli should be ruled out. Angiographic imaging of the aortic arch or 
transesophageal echocardiography should be considered in further diagnostic work-up.  
There are no clear trial data on the secondary prevention of recurrent CI in patients 
with complex aortic atheroma. The only one, but prematurely ended ARCH trial, 
concluded that antiplatelet treatment might be superior to anticoagulation. However, 
the result was not significant.68 
 
 





Endocarditis is an inflammatory disease affecting the endocardium. It is characterized 
by formation of protruding lesions, also called vegetations. Depending on their 
composition, endocarditis is classified as either infective endocarditis (IE) or 
nonbacterial thrombotic endocarditis (NBTE). The vegetations are predominantly 
distributed within the aortic and mitral valve. Both IE and NBTE may be a source of 
embolization to multiple organs, including the brain. It seems that mitral vegetations 
have a two times higher risk of cerebral embolization compared to vegetations 
localized within the aortic valve. This is probably linked to the usually more extensive 
and larger vegetations within the mitral valve. CI occurs as a complication in 
approximately 10% of patients with IE and in over 30% of patients with NBTE.  
The distribution of ischemic lesions in multiple arterial territories is common due to 
proximity of the source of embolization.69, 70  Neuroimaging patterns of IE-associated 
CI may be very heterogeneous in distribution and size. The ischemic lesions are prone 
to hemorrhagic transformation due to bacterial component of thrombi. NBTE-
associated CI has almost uniformly multiple-territory distribution, but hemorrhagic 
transformation is less frequent.70 
NBTE known as Libman-Sacks or marantic endocarditis represents a rare form of 
endocarditis. It is characterized by usually smaller micro-vegetations, consisting of 
sterile platelet-fibrin thrombi of non-infectious origin. The NBTE is mostly seen as an 
accompanying complication of other systemic diseases such as systemic lupus 
erythematosus (SLE), antiphospholipid syndrome (APS) but also advanced-stage 
malignancies. Predominantly adenocarcinomas, including lung, pancreatic or 
colorectal adenocarcinoma, give a higher risk of developing NBTE. The 
pathophysiology is not fully understood, but a hypercoagulable state and endothelial 
damage play probably an important role. The micro-vegetations in NBTE are very 
friable due to absence of inflammation. Thus, they tend to give recurrent embolization 
in multiple arterial territories.56, 71 MACI may be the first sign of on-going malignant 
processes or of other NBTE-associated diseases.  
Even though NBTE is a rare condition, it is probably overrepresented in patients with 
MACI and should be taken into consideration in the diagnostic work-up. Because of 




the small size of vegetations, NBTE is not easy to diagnose by standard transthoracic 
echocardiography (TTE). There is evidence that transesophageal echocardiography 
(TEE) is more sensitive for the diagnosis of NBTE then TTE.72 Another diagnostic 
tool aiming on the assessment of the effect of secondary prevention and risk of 
recurrent embolization in patients with endocarditis, is micro-emboli detection.73  
Several studies showed that intravenous thrombolysis for ACI related to endocarditis 
is associated with higher rates of ICH and worse outcome.74, 75 The treatment is in the 
first line based on management of the underlying disease in both IE and NBTE. 
However, the approach to secondary prevention differs. Unlike patients with IE, 
anticoagulation is routinely used in patients with NBTE, although there are no trials on 
secondary prevention of ischemic stroke in patients with NBTE. However, 
unfractionated or low-molecular-weight heparin are today the anticoagulants of 
choice.76 Vitamin K antagonist is not effective for NBTE and the effect of direct oral 
anticoagulants (DOAC) is not well documented. The secondary prevention in patients 
with IE on the other hand is more complex, and anticoagulation must be weighed 
carefully against the bleeding risk, which is higher than in patients with NBTE. 
Surgical treatment may be considered in both IE and NBTE under certain indications 
such as endocarditis-associated heart failure but also to prevent further embolization.   
Large artery atherosclerosis 
In patients with unilateral ICA, MACI are rarely seen. However, arterial variations 
such as fPCA or azygos ACA or cross-flow phenomenon may be an explanation for 
concomitant lesions in the posterior or contralateral anterior arterial territory.77 
Multifocal SACI are, however, frequent due to recurrent embolism from an unstable 
ICA stenosis.78 Multiple emboli or fragmentation of bigger emboli are possible 
mechanisms. These patients often present with hyperhomocysteinemia, probably due 
to plaque instability.  This may facilitate the differential diagnosis.79 High-grade 
stenosis increases the risk of developing watershed infarcts in border-zone areas 
topographically appearing as MACI.80 Watershed infarcts may be distributed over the 
ACA, MCA and PCA arterial territory.  
 




Patent foramen ovale 
Patent foramen ovale (PFO) is a reminiscence of the fetal communication between the 
left and right heart atrium, which fails to close postnatally and persists into adulthood. 
PFO is not rare, it is present in over 25% of the general adult population and the 
frequency among the patients with cryptogenic CI is 3-5 times higher. PFO 
hemodynamically represents a right-to-left shunt and is often attributed to paradoxical 
embolism in patients with cryptogenic stroke, mainly in young stroke patients.81 
MACI may occur among patients with PFO, but there is no strong evidence that 
multiple-territory pattern is more frequent in comparison to the non-PFO stroke 
population.82 It seems that PFO is associated with MACI in young stroke patients and 
the location of lesions was predominantly described in the posterior circulation.83, 84 
There was not a strong consensus whether the PFO closure is superior to antiplatelet 
therapy alone in the prevention of recurrent stroke. However, three clinical trials 
showed benefit of PFO closure combined with antiplatelet therapy,85 86, 87 and this 
procedure has become a routine in young cryptogenic stroke patients with PFO.  
 
Left ventricular thrombus  
Formation of a left ventricular thrombus (LVT) is an important complication of 
systolic cardiac dysfunction that may follow ST-elevation myocardial infarction 
(STEMI). The pathophysiology is based on blood stasis in the infarcted area of the 
heart. The presence of LVT increases the risk of embolic stroke four times, mainly in 
the first three months after STEMI.88 As in the case of other CE sources, a multi-
territory pattern of ischemic lesions is often reported.89 Before the era of percutaneous 
coronary intervention (PCI), the incidence of LVT after STEMI was up to 40%.90  The 
introduction of PCI decreased the rate to 2.7% in the general STEMI population and to 
7.5% in patients with anterior STEMI.91  However, LVT still remains an important 
source of emboli of cardiogenic stroke. Thus, in patients with non-lacunar ischemic 
stroke with multi-territory distribution, LVT should always be investigated as a 
possible cause. Anticoagulation with vitamin K antagonist is currently the secondary 




prevention of choice in patients with proven LVT. However, the ideal anti-thrombotic 
regime in these patients is still uncertain.92 
Since the effect of anticoagulation treatment in patients with embolic stroke of 
undetermined source (ESUS) is still unclear, the correct diagnosis of LVT is crucial. 
TEE is a gold standard in the diagnosis of LVT and is more sensitive than TTE. 
Recent studies have shown that contrast-enhanced cardiac MRI is superior to TEE and 
may thus substantially facilitate the choice of secondary prophylaxis in patients with 
ESUS. 
Endovascular and vascular interventions 
Mechanical thrombectomy (MT) or carotid endarterectomy, carry a risk of 
periprocedural complications, including thromboembolism. Arterial injury and 
prothrombotic features of the arterial devices, catheters or contrast agents are often 
responsible for adverse events.  
In MT, embolization may occur both within the downstream of the targeted artery, and 
within other arterial cerebral territories. The large clinical trials on MT reported 
embolization to different arterial territories in around 6% of cases.93 The mechanism of 
additional embolization in MT is usually caused by fragmentation of the clot during 
stent retrieval. In some cases, recanalization of these additional occlusions can be 
achieved by further MT passes or the administration of intra-arterial thrombolysis.94 
Cerebral embolization as a complication following carotid endarterectomy and 
stenting occurs in 3.3% and 7.3% of patients, respectively. The mechanisms of 
ischemic stroke are diverse, including hypoperfusion and embolism.95   
Along with wider use of newer and more accurate brain imaging methods, it is proven 
that a considerable number of patients undergo asymptomatic (silent) periprocedural 
embolization, often appearing as embolic micro-lesions. 
Left atrial myxoma  
Primary cardiac tumor is a very rare cause of stroke. However protruding tumor 
masses can be a potent source of embolization. Left atrial myxoma is the most 
common tumor of heart and represents 50-70% of cases. Left atrial myxoma should be 
considered in the etiological work-up mainly in young stroke patients having cardiac 




symptoms such as exertional dyspnea or signs of pulmonary edema. A neurological 
complication in the form of cerebral embolization occurs in approximately 30% of 
cases and shows often multiple-territory distribution.96, 97 Myxoma embolization may 
also lead to the characteristic formation of multiple intracranial aneurysms within the 
peripheral branches of intracranial arteries. This phenomenon is probably related to a 
weakening of the intracranial vessel walls following the infiltration of the vessel wall 
by spread myxomatous tumor cells.98 The first choice of treatment is surgical resection 
of the tumor.  
Small vessel disease 
The frequency of lacunar MACI among patients presenting with a lacunar syndrome is 
16%.99 It may be difficult to distinguish if the ischemic lesions occurred as 
simultaneous or as successive events within hours or days. Even though patients with 
lacunar MACI and SACI often share the same risk factors, there is evidence that in 
patients with lacunar MACI, a proximal source of emboli often co-exists.38 Some 
studies show that lacunar MACI often has another identifiable stroke cause than SVD, 
including artery-to-artery embolism, concomitant CE or LAA.38, 99, 100 Simultaneous 
occlusion caused by multiple microatheroma or lipohyalinosis may be an explanation 
in some of these patients.101, 102 However, only histological techniques may distinguish 
embolic, lacune-shaped lesions from true lacunar lesions. The varying results of 
studies show that the findings highly depend on the extensiveness of the diagnostic 
work-up in these patients. More intensified etiological investigation may influence the 
decision regarding secondary prevention in such patients. Diabetes mellitus and 
widespread leukoaraiosis are common risk factor in patients with lacunar MACI. 
These patients also have a higher risk of recurrent stroke and worse functional 
outcome which should be taken into consideration by the treating physician.103 
Recurrent and multifocal truly lacunar CI may also be a sign of more rare types of 
SVD, such as cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy (CADASIL). CADASIL represents a hereditary non-amyloid 
and non-atherosclerotic SVD caused by NOTCH 3 gene mutation. CADASIL should 
be considered in young stroke patients presenting with recurrent lacunar MACI, 
concomitant migraine attacks and cognitive deterioration.104, 105 




Antiphospholipid syndrome  
Antiphospholipid syndrome (APS) is a multi-organ autoimmune disorder accompanied 
by the presence of antiphospholipid antibodies (aPL) such as lupus anticoagulant or 
anticardiolipin antibodies. APS may start either as a primary disorder or as a 
complication of another autoimmune disease such as systemic lupus erythematosus 
(SLE). The prevalence of APS is up to five times higher among women and the 
clinical manifestation usually starts between 30-40 years of age. Major complications 
of APS are abortions and systemic thromboembolism (Hughes’ syndrome or sticky 
blood syndrome) with a high tendency of arterial embolism. Over 20% of young stroke 
cases may be associated with APS.106  The exact pathophysiology of the 
hypercoagulable state in APS is not completely understood. However, an interaction of 
aPL with the pathways of coagulation via an impaired function of protein C, platelets 
and fibrinolysis plays an important role.  
The arterial occlusion may be either of embolic or thrombotic origin. APS-associated 
nonbacterial thrombotic endocarditis (NBTE) usually stands behind the embolic 
stroke.107 Thrombosis is most probably associated with activation of platelets and 
endothelium in the cerebral arteries, thus promoting a hypercoagulable state in the 
affected vessel. As in other disorders accompanied by hypercoagulable state and 
NBTE, ischemic lesions often have multi-territory distribution, and the risk of 
recurrent stroke is high.24, 108  
There is lack of data and controversy regarding the correct secondary prevention in 
patients with APS-associated CI. Over 50% of patients experience a recurrent 
thromboembolic event when treated with aspirin or vitamin K antagonist at INR<3. 
Only aggressive long-term anticoagulation therapy with vitamin K antagonists at 
INR>3 seems to be effective secondary prophylaxis. But this therapeutic regime is 
complicated by a higher risk of bleeding.109 A catastrophic type of APS is defined by 
embolization to multiple organs within short time. Here, a high dose steroid treatment, 
i.v. immunoglobulins or plasma exchange alongside with anticoagulation treatment 
may be indicated.  The monitoring of treatment response may be achieved by 
microemboli detection, especially in patients presenting with MACI.73 
 





Another rare etiology of multi-organ thromboembolic event is the hypereosinophilic 
syndrome. Here, either idiopathic or secondary overproduction of eosinophils, that 
infiltrate various organs including cerebral vessels, may lead to a local 
hypercoagulable state. MACI has been reported in connection with this syndrome; 
however, only as case-reports.110, 111 The treatment can be complicated depending on 
the cause of eosinophilia. However, high-dose glucocorticoids seems to be effective in 
most cases.112 
Cancer  
The pathophysiology of cancer-associated thromboembolism is complex and involves 
several overlapping mechanisms. The most important mechanism is a hypercoagulable 
state mediated either by cancer itself or by oncological treatment like chemo- and 
radiotherapy. The Bergen NORSTROKE registry showed that prevalence of an active 
cancer among consecutively admitted stroke patients (within the interval of 12 months 
prior and after the index stroke) is 5%.113, 114 The frequency of thromboembolic events 
in cancer patients is estimated to approximately 15%, of which 3% represent CI. 
However, the number is probably underestimated as cancer-associated CI is 
underdiagnosed. Patients with active malignancy have a higher risk of a recurrent 
thromboembolic event of any type, with cumulative rates of 21%, 31% and 37% at 1, 
2, and 6 months, respectively.71  
It seems that predominantly highly aggressive and advanced-stage mucinous 
adenocarcinomas including lung, pancreas and colorectal cancer are associated with a 
higher occurrence of thromboembolic events. Some types of adenocarcinoma such as 
prostate or breast cancer, seem to play a minor role.  
The CI may be caused either by in-situ thrombosis or cardiac embolism in relation to 
NBTE. Prior studies showed that a multi-territory distribution of ischemic lesions is 
frequent.54 One study showed that up to 20% of MACI with involvement of all three 
territories are cancer-related.115 MACI may be the first symptom of occult cancer. 
Patients at the same time presenting with worrisome symptoms, such as weight loss, 
lack of appetite and elevation of biomarkers characteristic for thromboembolic events, 
should always undergo cancer screening.54, 115  Very high levels of D-Dimer (≥3 mg/L) 




and fibrinogen/fibrin degradation products (FDP) and low level of serum hemoglobin 
(≤12.0 g/dL) are often seen in patients with cancer-associated CI. These blood tests 
may serve as a sensitive predictive factor; albeit with low specificity.116, 117 The cut-off 
point for differentiation cancer-associated MACI from CE-associated MACI was 
suggested to be 2 µg/mL of D-Dimer.118  
In cancer-associated CI, both thrombolysis and thrombectomy may be beneficial after 
careful consideration of eligibility. The secondary prevention in cancer-associated CI 
is challenging. Except for the prematurely terminated TEACH-trial, which randomized 
patients with cancer-associated CI to aspirin and enoxaparin, no other clinical trials 
have been published to this date.119 Empiric treatment with low-molecular heparin 
under the control of the therapeutic range of anti-factor Xa seems to be effective and 
safe. However, high price and daily subcutaneous administration are major drawbacks. 
Secondary prevention with DOAC may be effective, but supporting data are not yet 
available.  
Vasculitis 
Vasculitis of the central nervous system encompasses a wide range of blood vessel 
autoinflammatory diseases of either primary or secondary origin. In contrast to the 
secondary form where disturbance of CNS accompanies a systemic vasculitis, the 
primary form is limited only to the CNS. The clinical picture may vary; however, 
cognitive deterioration, headache, and focal neurological deficits are the most 
characteristic symptoms. The prevalence of vasculitis-associated CI, regardless of 
primary or secondary origin, is only 0.2% in the general stroke population and 
therefore a routine screening is not recommended.120  However, in young stroke 
patients with ischemic lesions of different ages and distribution in several arterial 
territories, CNS vasculitis should be considered as differential diagnosis. The lesions 
are usually distributed in both hemispheres with lesions in cortical as well as 
subcortical areas.121  The diagnosis of primary CNS vasculitis is based on angiographic 
imaging, but CNS biopsy may be needed for final confirmation. Glucocorticoids are 
usually an effective treatment and may prevent further complications and negative 
progression.122 There are several case reports on MACI accompanying secondary 




vasculitis such as Takayasu arteritis and Churg-Strauss syndrome. These should be 
suspected in the context of a systemic disease.123-125 
 
Diagnostics 
Clinical Manifestation  
Patients with MACI may present with unusual clinical manifestation as more than one 
arterial territory is affected.  The examining physician may encounter bilateral 
neurological deficit or an atypical combination of symptoms usually not seen in 
patients with SACI. In one prospective cohort study comprising 80 patients diagnosed 
with MACI, only 24 patients (30%) showed signs of multi-territory clinical 
manifestation.33 Presumably, several factors may influence the clinical manifestation 
of MACI, such as the character of the ischemic lesions. 
The role of neuroimaging  
The non-contrast computed tomography (CT) is used as standard initial brain imaging 
in most patients with suspected stroke. The CT is the method of choice for prompt 
diagnosis of brain hemorrhage or large-volume ACI. Most ACI, however, are not 
visible on CT during the first several hours. Only chronic white-matter disease or old 
ischemic lesions may suggest the presence of cerebrovascular disease, however 
multiple chronic ischemic lesions localized cortically may be suggestive of an active 
embolic source.  
MRI has in the acute setting a much higher sensitivity to identify ACI compared to CT 
(83% vs. 26%).126 Its sensitivity increases to 97.5% by use of Diffusion- and 
Perfusion-Weighted MRI.127 DWI-MRI has become a cornerstone in the diagnostics of 
acute ischemic lesions identifiable already within minutes of ischemia which found its 
use mainly in patients with unknown onset of stroke. Nevertheless, MRI is a time-
demanding and expensive examination, and its availability for acute stroke diagnostics 
is still limited in the majority of hospitals.  
MRI is nowadays an essential part of the diagnostic follow-up in stroke patients. 
Several specific sequences have been introduced in the past two decades, adding 
additional information on stroke subtype and etiology. Other modalities such as 




CT/MR angiography (CTA/MRA) or CT/MR-Perfusion are increasingly implemented 
in the initial neuroimaging protocols in order to localize an arterial occlusion and to 
distinguish salvageable brain tissue from the irreversible infarct core.15, 16 CTA/MRA 
should always be a part of the stroke protocol in patients with MACI in order to 
exclude anatomical variations of intracranial arteries which may be responsible for 
such topographical distribution. CTA/MRA is also a useful method for diagnostics of 
intracranial stenosis but also less common causes of MACI including vasculitis or 
Moyamoya disease. 
The distribution and pattern of MACI as defined by MRI may be suggestive of the 
etiology. MACI of both small and large volumes, particularly with cortical 
distribution, favours proximal embolic sources such as heart or aortic arch. A lacunar 
pattern of MACI may suggest advanced SVD and simultaneous occlusion of the deep-
perforators. Severe leukoaraiosis and multiple microbleeds on FLAIR and 
susceptibility-weighted imaging (SWI) may support SVD origin. Multiple infarcts 
within only one arterial sub-territory may suggest an artery-to-artery embolism from 
the supplying intracranial artery. A combination of multiple cortical and subcortical 
ischemic lesions within one arterial territory may be caused by fragmentation of the 
emboli, as often seen in unstable ICA stenosis. Unilateral border-zone (watershed) 
infarcts are usually associated with stenosis or occlusion of the ipsilateral ICA. 
Bilateral watershed infarcts rather point towards systemic hypoperfusion.41, 128 
As in other areas of neuroimaging, the field strength of MRI has an implication on the 
precision and quality of the findings. In contrast to the routinely used 1.5T MRI, MRI 
with higher field strengths may reveal additional micro-lesions. Two studies using a 
3.0 T MRI scan showed a significantly higher frequency of MACI in their stroke 
cohorts.44, 129 
Cardiogenic embolism 
AF should always be investigated as a cause of MACI. A normal standard ECG 
without relevant arrhythmias should be followed by long-term ECG monitoring. 
Several studies showed that the detection rate of silent (paroxysmal) AF improves with 
prolonged ECG monitoring. Both 72 hours and continuous ECG monitoring at a stroke 
unit appear to be superior to standard 24-hours examination.130, 131 Several devices 




capable of even higher detection rates have been introduced. Implantable loop 
recorders require only a minor surgical procedure and may be used for up to 3 years of 
continuous monitoring. However, new devices such as chest and thumb-ECG or 
smartwatches seem to be a less invasive and resource-demanding alternative for AF 
detection.132, 133  
Echocardiography plays an important role in the evaluation of structural cardiac 
sources of emboli. Transthoracic echocardiography (TTE) is sufficient in many 
patients with heart disease, but transesophogeal echocardiography (TEE) has been 
shown to be superior to standard TTE.  One prospective study showed that 40% of 
CI/TIA patients with normal findings on TTE showed structural signs associated with 
cardiac emboli sources on TEE.134  The prevalence of potential aortic or cardiac 
sources diagnosed by TEE is high among patients with CI regardless of the vascular 
distribution. TEE seems to be beneficial in patients with suspected NBTE as a more 
common cause of MACI.72 However, MACI alone should not be an indication to 
perform TEE.135  
Microemboli detection  
Microemboli detection by transcranial Doppler ultrasound is a useful, non-invasive 
and inexpensive method to identify silent embolization to the cerebral arteries. Silent 
embolization increases stroke risk and may be a sign of inadequate antithrombotic 
treatment.136, 137 MACI often indicates the presence of a highly active source of emboli 
accompanied by a higher risk of recurrent CI. Microemboli detection should be used 
more extensively in patients with MACI in order to avoid a negative progression and 
to assess the effect and possibly adjust the strategy of secondary prevention of 
recurrent stroke.73  
 
Ischemic stroke recurrence 
After an ACI, the patient is at high risk of recurrent stroke, readmission for another 
health issue and death, especially within the first weeks after the index stroke. The 
highest risk of early recurrence is in patients with stroke due to large artery 
arteriosclerosis.138, 139 Initial plaque instability and low immediate effect of the 
antiplatelet and cholesterol-lowering treatment may play an important role. 




Endarterectomy performed early may prevent such events. However, not all patients 
have an indication for this procedure.140 CI categorized as other disease TOAST 
subtype is prone to higher recurrence as well. The explanation may be the rarity of the 
underlying etiologies as well as hypercoagulable states which may be difficult to get 
under control.71, 141 On the other hand, the high recurrence in cardioembolic stroke 
seems to have decreased in the last years. It is most probably caused by the 
introduction of highly effective and safer direct oral anticoagulants.139 
Multi-focal ischemic lesion pattern either within one or several arterial territories is an 
independent predictor for early recurrent stroke, readmission for another vascular 
event and death.129, 142  In patients with MACI, predominantly large artery 
atherosclerosis and other disease TOAST subtype are associated with a higher risk of 
early recurrence. One recent study showed that MACI in patients with undetermined 
etiology TOAST subtype also are associated with higher long-term stroke 
recurrence.143 The patients with MACI reported in that study had significantly higher 
D-Dimer level and occurrence of right-left shunting.  This mirrors the importance of 
the long-term risk of embolism in patients with both cancer and PFO. On the other 
hand, a sub-analysis of the CHANCE trial, aiming at patients with minor stroke, 
showed that there is no significant difference in the recurrence between patients with 
non-lacunar SACI and MACI. Lacunar stroke seems to have a lower risk of recurrence 
compared to non-lacunar strokes.144 
There are not sufficient data on short- or long-term clinical or functional outcome of 
patients with MACI. The same applies for complications. Overall, patients with an 
index or recurrent MACI may be at a higher risk of recurrent stroke, which may 









Aims of the dissertation 
MACI are not a rare entity in stroke medicine, but few data on MACI has been 
published. There is still a need to clarify some of the pathophysiological and clinical 
aspects. The aim of this dissertation is to contribute to this less documented field of 
stroke medicine by using the Bergen NORSTROKE registry comprising a 
considerable number of well-described patients with MACI.  
Aims: 
Paper-I 
1. To assess the frequency and the etiological spectrum of MACI based on the 
TOAST classification.   
2. To assess gender and age distribution in patients with MACI.  
Paper-II 
3. To compare frequencies of LAA- and CE-associated MACI in relation to the 
time from stroke onset to time of MRI examination.  
Paper-III 
4. To compare short-term in-hospital complications in patients with MACI and 
SACI.   
5. To compare short-term clinical and functional outcome in patients with MACI 
and SACI.  
Paper-IV 
6. To assess the frequency of single- vs, multiple-territory clinical manifestation 
on admission among the patients with MACI. 
7. To assess clinical and radiological aspects associated with single- vs, multiple-
territory clinical manifestation. 
 





The Bergen NORSTROKE registry 
The Bergen NORSTROKE registry contains comprehensive information on medical 
history and baseline and in-hospital clinical characteristics up to discharge of all 
patients diagnosed with stroke/TIA consecutively admitted to the stroke unite in the 
Department of Neurology, Haukeland University Hospital, Bergen, Norway. The 
registry has a prospective design characterized by collecting data determined prior to 
the start of the registration. For this purpose, a standardized case report form is used 
for each patient. The inclusion started in 2006 and is still on-going. 
Haukeland University Hospital covers a catchment area of almost 300.000 inhabitants. 
However, young stroke patients under 60 years and patients with large vessel 
occlusion eligible for MT are transferred from neighboring regional hospitals and are 
included in the registry as well. Bergen NORSTROKE registry has been approved by 
local ethics committee REK West. 
The first two papers (I-II) published in 2016 are based solely on the data from the 
Bergen NORSTROKE registry acquired in the time period from 2006 to 2013.19, 145 
The data for the last two papers (III-IV) published in 2019 and 2020 are gathered from 
the extended version of the Bergen NORSTROKE registry, which is from 2006 to 
2017.22 The paper-IV required additional data on patients with MACI (N=311), which 
were obtained by reviewing the admission medical records and DWI-MRI findings.  
 
Baseline characteristics 
All stroke/TIA patients undergo an initial clinical examination, including National 
Institutes of Health Stroke Scale (NIHSS) and supplemental neurological assessment, 
performed by the on-duty neurology resident in the emergency room. The initial brain 
imaging involves in most of the patients with suspected stroke/TIA, brain native CT or 
native CT + CTA if indicated. Initial MR or MR + MRA was performed in patients 
with unknown time of symptom onset such as those who wake up with stroke 
symptoms (“wake-up stroke protocol”) or those patients where CT was contraindicated 




such as pregnant women. Baseline vital signs, ECG and a set of blood tests specific for 
patients with suspected stroke/TIA were taken in the emergency room.  
 
Medical history and risk factors 
Cerebrovascular and cardiovascular medical history, stroke risk factors and other 
relevant information were obtained during the hospitalization and registered in the 
case report form.  
 
Diagnostic work-up 
Every patient with CI or TIA underwent comprehensive diagnostic work-up including 
cardiological, neurosonological and radiological assessment indicated as appropriate.  
Cardiological assessment  
If the initial ECG showed no atrial tachycardia such as AF, atrial flutter or ectopic 
atrial tachycardia, long-term ECG monitoring lasting 24- / 48- / 72- hours was 
performed. The structural sources of aortic or cardiac embolism were assessed by TTE 
or by TEE if indicated.  
Neurosonological assessment 
Sonographic evaluation of extracranial arteries was regularly performed by either 
stroke neurologist or trained neurology resident. Details on stenosis grade, dissection, 
occlusion or other relevant pathologies of extracranial arteries were registered. ICA 
stenosis was defined as symptomatic if the stenosis >50% is accompanied by 
ipsilateral symptomatic ACI/TIA. Stenosis >50% with no ipsilateral symptomatic 
ACI/TIA was defined as an asymptomatic ICA stenosis. Transcranial duplex and 
microemboli detection were performed if indicated.  
Radiological assessment 
The majority of patients with stroke/TIA were examined by MRI the same or the next 
day. The Department of Radiology at Haukeland University Hospital provides several 
MRI machines of either 1.5 or 3.0 Tesla field strength. The vast majority of patients 
included in the Bergen NORSTROKE registry were examined by a 1.5T MRI machine 




and only a smaller portion had examination by 3.0T MRI machine. Specifications of 
MRI machines used at Haukeland University Hospital in 2020 are listed in table 5. 
Both the on-duty neuroradiologist and the stroke neurologist (HN) assessed the MRI 
scans.  
 
Table 5. Specifications of MRI machines at Haukeland University Hospital 
Field strength (T) 1.5 3.0 
MRI scanner Siemens Healthcare Siemens Healthcare 
Head coil – nummer of channel 8 32 
B value (s/mm2) 0, 500, 1000 0, 500, 1000 
Repetition time - TR (ms) 3700 3400 
Echo time - TE (ms) 89 54-89 
Field of view (mm) 230 x 230 220 x 220 
Matrix size 192 x 192 160 x 160 
Slices 23 26 
Slice thickness (mm) 5 mm with 1 mm gap 4 mm with 1,2 mm gap 
MRI – magnetic resonance imaging 
 
Young stroke 
Besides the standard diagnostic work-up applied in stroke/TIA patients, young stroke 
patients under 60 years undergo a more comprehensive diagnostic work-up to exclude 
rare causes of stroke. Blood tests including tests on thrombophilia, comprehensive 
neurosonological and cardiological examinations were performed.  
Etiology and classification 
Based on the diagnostic work-up, the etiology in every patient diagnosed with CI/TIA 
was classified using TOAST criteria as cardiogenic embolism, large artery 
atherosclerosis, small vessel disease, other disease or unknown etiology. TOAST 
subtype unknown etiology (UE) comprises patients with competing etiologies, 
cryptogenic stroke or incomplete diagnostic work-up.17 
Based on the clinical manifestation and radiological findings, every CI was also 
categorized using the Oxfordshire Community Stroke Project (OCSP) classification as 
total anterior circulation infarct clinical stroke syndrome (TACI), partial anterior 
circulation infarct clinical stroke syndrome (PACI), lacunar infarct clinical stroke 




syndrome (LACI) or posterior circulation infarct clinical stroke syndrome (POCI).146 
Table 6 shows OCSP classification in detail.  
Table 6. Oxfordshire Community Stroke Project (OCSP) classification 
TACI PACI LACI POCI 
Clinical manifestation 












motor and/or sensory 
deficit in at least two 
out of the following: 
face, arm, and leg 
 











motor and/or sensory 
deficit in at least two 
out of the following: 
face, arm, and leg  
One of the syndromes: 
 
1-Pure motor stroke 
 










One of the following: 
 
1-ipsilateral cranial 
nerve palsy with 
contralateral motor 
and/or sensory deficit 
 
2-bilateral motor 











or cortical blindness 
 
Radiological finding 
Large cortical MCA 
infarcts or >1/2 of the 
MCA territory + ACA 
or PCA territory  
 
medium sized cortical 
infarcts (<1/2 of MCA 
territory) 
 




Small sized cortical 
infarcts (<¼ of MCA 
territory) or any of 
ACA territory 
 
medium sized cortical 
infarcts (<1/2 of MCA 
territory) 
 
watershed infarcts  
 
large > 1.5cm 
subcortical infarcts 
Small <1.5 cm 
subcortical infarcts 
 
Cortical infarct in PCA 
territory 
 
Brainstem infarct or 
cerebellar infarct  
TACI - total anterior circulation infarct clinical stroke syndrome, PACI - partial anterior circulation 
infarct clinical stroke syndrome, LACI - lacunar infarct clinical stroke syndrome; POCI - posterior 
circulation infarct clinical stroke syndrome; ACA – anterior cerebral artery, PCA – posterior cerebral 
artery; MCA – middle cerebral artery 
 




Stroke severity on admission and short-term outcome 
Stroke severity on admission and the in-hospital stroke-related neurological deficit was 
assessed by NIHSS score. NIHSS represents a scale from 0 to 42, assessing the 
severity of stroke but NIHSS also gives clues as to the probable topographical location 
of the ischemic lesion(s).147 Both validity and reliability have been proven high in 
clinical trials.148, 149 After the admission, the NIHSS score was assessed at pre-
specified time points up to day 7, or discharge if earlier, to evaluate neurological 
improvement or deterioration during hospitalization. NIHSS score on admission, the 
next day and on day 7 or at discharge were assessed by a neurology resident or stroke 
neurologist.  
For the assessment of short-term functional improvement or deterioration, modified 
Rankin Scale (mRS) was used. MRS is a widely used scale evaluating functional status 
(0 - no symptoms up to 6 – death) and works as an indicator of the degree of 
disability/dependence after a neurological event.150 mRS is used in the majority of 
clinical trials as a primary outcome measure of an intervention effect. The interval 0-2 
is generally considered as a favorable outcome and the interval 3-6 as an unfavorable 
outcome. The functional status both before the admission and on day 7 or at discharge 
was assessed by a certified stroke nurse. 
Relevant in-hospital complications during the hospitalization, including deep venous 
thrombosis (DVT), myocardial infarction (MI), recurrent ACI, pulmonary embolism, 
symptomatic and asymptomatic ICH, heart failure, epileptic seizure, pneumonia, 
infection of unknown focus, urinary tract infection, urinary retention, urinary 
incontinence or death were registered.   
 
Definition of MACI 
Only patients with acute ischemic lesions revealed by DWI-MRI were included in the 
four papers. MACI was defined as at least two non-continuous ischemic lesions in at 
least two arterial cerebral territories. There are two frontal arterial cerebral territories 
represented by left and right side of the anterior circulation supplied by ACA and 
MCA originating from ICA. There is one posterior arterial cerebral territory 
represented by the posterior circulation supplied by posterior inferior cerebellar 




arteries, anterior inferior cerebellar arteries, superior cerebellar arteries and PCA 
originating from BA.151 Only DWI-MRI lesions appearing as hyperintense signals 
accompanied by hypointense signals on apparent diffusion coefficient magnetic 
resonance imaging (ADC-MRI) were considered as acute. Patients with slightly 
hyperintense DWI-MRI signals or those DWI-MRI signals without corresponding 
ADC-MRI changes were considered as subacute lesions or artefacts.  
The abbreviation “MACI” stands for “Multiple Acute Cerebral Infarcts”. However, 
“acute cerebral infarct(s) in multiple arterial territories” is a more precise description. 
We decided to keep the abbreviation MACI for its simplicity. 
 
Clinical manifestation and topographical distribution of MACI 
The clinical manifestation and topographical characteristics of MACI were assessed by 
a non-blinded retrospective review of the admission medical records and 
corresponding DWI-MRI, performed independently by two PhD-fellows in stroke 
medicine (Vojtech Novotny and Sander Johan Aarli).  
Patients with MACI were categorized into 7 groups according to clinical manifestation 
corresponding to (1) left anterior territory + posterior territory (LAPT), (2) right 
anterior territory + posterior territory (RAPT), (3) left + right anterior territory 
(LRAT), (4) all three territories (LRAPT), (5) left anterior territory (LAT), (6) right 
anterior territory (RAT) or (7) posterior territory (PT).  
Based on the combination of the affected arterial territories, the topographical 
distribution of MACI was categorized into four groups as follows: (1) LAPT, (2) 
RAPT, (3) LRAT or (4) LRAPT. The number of lesions was categorized as <5, 5-10, 
>10. 
To reach a methodological agreement, both reviewers assessed the first 50 patients 
simultaneously. Further assessment of the 261 patients was performed independently, 
and the results were compared.  All results which the reviewers agreed on were kept 
for the final analysis. In case of disagreements, the patients were reassessed in a joint-
review, and the consensus was used for final analysis. 





Paper I & II 
The first two papers published in 201619, 145 are based on The Bergen NORSTROKE 
registry comprising all stroke/TIA patients consecutively admitted to the stroke unit 
affiliated to Haukeland University Hospital from February 2006 to October 2013. All 
patients diagnosed with ICH (N=371) and TIA (N=348) were excluded. Patients 
diagnosed with ACI where the diagnosis was based only on CT (N=477) or DWI-MRI 
sequence showed no correlate (N=95) were excluded as well. Out of 2125 patients 
diagnosed with ACI confirmed by DWI-MRI, 187 (8.8%) had MACI, and 1938 
(91.2%) had SACI.  
Figure 3. Flowchart of patients included in the Paper-I and Paper-II 
  
TIA - transient ischemic attack; ICH - intracranial hemorrhage; ACI – acute cerebral infarct; DWI-
MRI - diffusion weighted magnetic resonance imaging; MACI – Acute cerebral infarct(s) in multiple 

























Paper III & IV 
The last two papers published in 2019 and 2020 are based on The Bergen 
NORSTROKE registry comprising all stroke/TIA patients consecutively admitted to 
the stroke unit affiliated to Haukeland University Hospital from February 2006 to 
January 2017.22 All patients diagnosed with ICH (N=548) or TIA (N=500) were 
excluded. Patients diagnosed with ACI where the diagnosis was based only on CT 
(N=634) or DWI-MRI sequence showed no correlate (N=156) were excluded. Out of 
3343 patients diagnosed with ACI confirmed by DWI-MRI, 311 (9.3%) had MACI 
and 3032 (90.7%) had SACI. In the paper-IV, only patients with MACI underwent the 
final analysis (N=311), of which 89 (28.6%) had acute cerebral infarct(s) in multiple 
arterial territories with multi-territory clinical manifestation (MACI-M) and 222 
(71.4%) had acute cerebral infarct(s) in multiple arterial territories with single-territory 
clinical manifestation (MACI-S).  




























TIA - transient ischemic attack; ICH - intracranial hemorrhage; ACI – acute cerebral infarct; DWI-
MRI - diffusion weighted magnetic resonance imaging; MACI – Acute cerebral infarct(s) in a multiple 
arterial territories; SACI - Acute cerebral infarct(s) in a single arterial territory; MACI-M - acute 
cerebral infarct(s) in multiple arterial territories with multi-territory clinical  manifestation; MACI-S - 
acute cerebral infarct(s) in multiple arterial territories with single-territory clinical  manifestation 
 
Statistics 
Paper-I, -II, -III and -IV 
For the univariate analyses, we used a χ2 test, t-test or Wilcoxon rank-sum test 
depending on the type of variable and skewness of the data.  
Paper -I, -III and -IV 
For the multivariate analyses, we used either logistic regression analysis or linear 
regression analysis to obtain odds ratio and 95% confidence interval or coefficient and 
95% confidence interval, respectively.  Statistically non-significant variables from the 
univariate analyses, however clinically relevant, were included in the multivariate 
analyses as cofounders (sex, age, mRS before admission, NIHSS on admission, etc.). 
Independent (exposure) and dependent (outcome) variables were applied as 
appropriate.  
Paper-I 
To visualize the relationship between age and occurrence of MACI, the LOWESS 
(Locally Weighted Scatterplot Smoothing) was used.  
Paper-II 
Histogram was used to visualize frequency of patients with MACI in relation to the 
time from the stroke onset to the MRI examination. To express the correlation between 
time from stroke onset to MRI examination and the frequency of different etiological 
groups among patients with MACI, we used Pearson's correlation with a coefficient (r) 
as an indicator of either positive, negative or no correlation. We used linear prediction 
models together with corresponding confidence intervals to visualize the frequency of 
MACI in different etiological groups in relation to the time from stroke onset to MRI 
examination. 





Depending on the distribution and skewness of the data, the descriptive statistics, 
including measures of central tendency and dispersion of the data were expressed by 
the mean or median and standard deviation or interquartile range, respectively. The 
level of significance was set to ≤ 0.05. All analyses were performed by using Stata 
(StataCorp, College Station, Texas, USA); version 14.0 for Paper-I and -II and version 












The final analysis included 2125 patients (78.8%) with ACI confirmed on DWI-MRI. 
Patients with MACI represented 8.8% of the studied cohort. 
Univariate analysis showed that patients with MACI were older (71.7 vs. 68.9 years; 
P=0.013), more often females (48.7% vs. 39.1%, P=0.011) and had higher mean 
NIHSS on admission [6.9 (SD=7.5) vs. 4.9 (SD=5.8)] compared to patients with 
SACI. However, in the multivariate analysis, neither female sex (OR=0.76; 95% CI 
0.54 – 1.1; P=0.13) nor higher age (OR=1.0; 95% CI 1.0-1.02; P=0.31) were 
associated with MACI. 
Cardiogenic embolism (35.8 % vs. 28.7%; P=0.042), atrial fibrillation (35.3% vs. 
24.8%; P=0.002) and also symptomatic (27.5% vs. 19.1%; P=0.014) and 
asymptomatic (16.2% vs. 10.5%; P=0.036) ICA stenosis appeared to be associated 
with MACI. Small vessel disease (3.7% vs. 14.3%; P< 0.001) and lacunar infarcts 
(15.5% vs. 26.1%; P=0.001) were associated with SACI. The association of 
cardiogenic embolism and symptomatic ICA stenosis with MACI remained significant 
in the multivariate analysis with OR of 1.5 (95% CI 1.1 – 2.3; P=0.025) and 1.9 (95% 
CI 1.2 – 2.8; P=0.003), respectively.   
When patients classified within the CE TOAST category were excluded, both 
symptomatic (35% vs. 25%; P=0.037) and asymptomatic ICA stenosis (20% vs. 13%; 
P=0.031) remained significantly associated with MACI.  




This study was based on a cohort of 2125 patients with ACI confirmed by DWI-MRI, 
of which 187 (8.8%) had MACI. The etiology based on TOAST criteria among 
patients with MACI was as follow: CE – 67 (35.6%); LAA – 19 (10%); SVD – 7 
(3.7%); OC – 6 (3.2%), UD – 88 (47%). In the MACI group, 24 patients (12.8%) had 
symptomatic ICA stenosis and 41 (21.9%) had asymptomatic ICA stenosis. The mean 




time from stroke onset to MRI examination in the whole cohort was 2.3 (SD=2.6) 
days, in patients with MACI 2.5 days (SD=2.6) and patients with SACI 2.3 days 
(SD=2.6).  
There was a positive correlation between time from stroke onset to MRI examination 
and the frequency of LAA-associated MACI (r=0.2; P=0.001), but also the frequency 
of MACI patients with symptomatic (r=0.14; P=0.01) and asymptomatic ICA stenosis 
(r=0.21; P=0.006).  There was no correlation between time from stroke onset to MRI 
examination and the frequency of CE-associated MACI (r= -0.02, P=0.61).  
In a sub-analysis of 93 patients with MACI in the anterior circulation only (MACI-A), 
the correlation was stronger for LAA-associated MACI (r=0.27; P=>0.001) as well as 
for symptomatic (r=0.27; P=>0.001) and asymptomatic ICA stenosis (r=0.28; 
P=0.001). There was no correlation with CE-associated MACI-A (r=0.5; P=0.33). 
Among the 93 patients with MACI-A, 25 had ICA stenosis, of which 11 (44%) had 
symptomatic ICA stenosis and 14 (56%) had a combination of symptomatic and 
asymptomatic ICA stenosis. In patients with MACI-A and concomitant symptomatic 
and asymptomatic ICA stenosis (N=14), most of the symptomatic ACI had either 
mixed (N=6) or a watershed (N=5) pattern on DWI-MRI.  
 
Paper-III  
The final analysis comprised 3343 patients with ACI confirmed by DWI-MRI, of 
whom 311 (9.3%) had MACI.   
Univariate analysis showed that that MACI occurred more often in older patients (74.5 
vs. 71.1 years; P<0.001) and more often in females (48% vs. 40%; P=0.008). Both 
median NIHSS score on admission [4 (IQR= 1-9) vs. 2 (IQR=1-5); P<0.001] and 
median mRS prior to the admission [0 (0-2) vs. 0(0-0); P<0.001] were higher in 
patients with MACI compared to the patients with SACI. Patients with MACI had a 
lower mean serum cholesterol (5.0 mmol/l vs. 5.3mmol/l; P=0.014) and LDL on 
admission (3.1 mmol/l vs. 3.4 mmol/l; P=0.006). Cardiogenic embolism was more 
common in patients with MACI (53% vs. 28%; P<0.001). On the other hand, both 
small vessel disease (3% vs. 15%; P<0.001) and unknown etiology (33% vs. 42%; 




P=0.004) were more common in patients with SACI. Patients with MACI also had 
more often AF (39% vs. 26%; P<0.001) and were more often anticoagulated prior to 
the admission (11.6% vs. 8.3%; P=0.048). Mechanical thrombectomy was more often 
performed in patients with MACI (10.1 vs. 2.6%; P<0.001). Secondary prevention 
with anticoagulation was more often started in patients with MACI (59.5% vs. 34.7%; 
P<0.001), whereas patients with SACI more often started with antiplatelet treatment 
(67.6% vs. 38.3%; P<0.001) and cholesterol-lowering medication (72.4% vs. 66.9%; 
P=0.023).  
In the final analysis, MACI was associated with both higher NIHSS and mRS at day 7 
or discharge if earlier, with adjusted coefficient 0.57 (95% CI=0.15-0.99; P=0.007) 
and 0.17 (95% CI=0.03-0.32; P=0.018) respectively. MACI was also associated with 
complication/-s regardless type, DVT and MI with adjusted OR 1.35 (95% CI=1.02-
1.79; P=0.035), 6.59 (95% CI=1.4-30.99; P=0.017) and 2.73 (95% CI=1.23-6.02; 
P=0.013), respectively.  
There were 8 patients who got DVT in the first week after the admission, 4 in the 
MACI group and 4 in the SACI group. All four patients in the MACI group had active 
cancer, whereas no patient in the SACI group had a history of a cancer (P=0.005). The 
patients with MACI and MI during the in-hospital stay had more often concomitant 
AF compared to the patients with SACI and MI (70% vs. 32%: P=0.037). 
Paper-IV  
Of the 311 patients diagnosed with MACI, 222 (71.4%) had single-territory clinical 
manifestation (MACI-S).  
NIHSS on admission was higher in patients with MACI-M compared to those with 
MACI-S [5 (IQR=2-11) vs. 3 (IQR=1-8); p=0.036]. Patients with MACI-M were more 
often categorized as TACI (29.2% vs. 13.5%; P=0.001), whereas patients with MACI-
S who were more often categorized as PACI (32.6% vs. 47.3%; P=0.016). The 
distribution of MACI in the left anterior + posterior territory was more common in 
patients with MACI-S (20.7% vs. 9%; P=0.014). The distribution of MACI in all three 
territories was more common in patients with MACI-M (37.1% vs. 18%; P <0.001). 
Patients having less than five ischemic lesions presented more often with single-
territory clinical manifestation (54.5% vs. 40.5%; P=0.025) and those having >10 




ischemic lesions presented more often with multi-territory clinical manifestation (36% 
vs. 19.4%; P=0.002).  
After adjustment for NIHSS on admission, sex and age, TACI, involvement of all 
three territories and >10 ischemic lesions remained significantly associated with 
MACI-M, with an adjusted OR (aOR) of 3.31 (95% CI = 1.39-7.86; P=0.007), 2.58 
(95% CI = 1.49-4.5; P=0.001) and 2.3 (95% CI = 1.32-4.01; P=0.003), respectively. 
PACI, involvement of the left anterior + posterior territory and <5 ischemic lesions 
remained significantly associated with MACI-S with an aOR of 0.57 (95% CI = 0.34-










The frequency of MACI in the Bergen NORSTROKE registry is in accordance with 
other studies applying a comparable methodology. In Paper-I, comprising 2125 patient 
with DWI-MRI, we found MACI in 8.8%.145 The extended cohort of 3343 patients in 
Paper-III showed a slightly higher frequency of 9.3%.152 Almost all patients included 
in the studies were examined by 1.5T MRI. This may have underestimated the true 
frequency. Two studies showed that 3.0 T DWI-MRI may detect additional acute 
micro-lesions, not seen with 1.5T MRI.44, 129 On the other hand, a study comparing the 
accuracy of 1.5T and 3.0T DWI-MRI in diagnosis of ACI within the first 6 hours 
showed that both sensitivity and specificity were actually lower for 3.0T DWI-MRI 
and questioned its diagnostic power for the hyperacute ACI.153 It seems that 3.0T 
DWI-MRI is less accurate in the hyper-acute stage of ACI despite higher signal-to-
noise ratio than in 1.5T DWI-MRI.  
A higher number of mechanical thrombectomies (MT) performed in 2014-2017 may 
explain a slightly higher frequency of MACI in the extended cohort. In the 8 years 
period from 2006 to 2013, only 44 MT were performed in total, more often in patients 
with MACI (5.95% vs. 1.72 %; P<0.001). However, in the additional period from 
2014 to January 2017, 62 MT were performed in total and the frequency of MT 
increased to 9.4% in the MACI group compared to 2.6% in the SACI group (p>0.001). 
We assume that peri-procedural cerebral embolization partly contributes to the 
increasing number of MACI. Our study shows that females are prone to have MACI 
relatively more frequently. In the MACI group, females were more often represented 
than in the SACI group (49% vs. 39%; P=0.011). Even though AF is more prevalent in 
males,154 females with AF are at higher risk of stroke compared to males regardless of 
anticoagulant treatment,155 which may explain our finding.  The overall age in the 
MACI group was higher than in the SACI group which may be related to higher 
occurrence of risk factors of CE, including AF, but also due to other disorders linked 
to hypercoagulable states.156 Figure 5 shows relatively higher clustering of patients 
with MACI in the area of higher age (upper X axis).  
 




Figure 5. Age distribution of patients with SACI vs. MACI  
 
Bergen NORTROKE registry (2006-2016);  
MACI – Acute cerebral infarct(s) in multiple arterial territories; SACI - Acute cerebral  
infarct(s) in a single arterial territory 
 
The etiology of MACI 
The number of patients with specified cause of ACI increases along with the 
introduction of new, more advanced diagnostic methods, such as neuroimaging, 
improved supplementary diagnostic tests and better understanding of stroke 
pathophysiology.157, 158 However, over one-quarter of all CI are, based on TOAST 
criteria, still classified as of undetermined etiology. This may be caused by incomplete 
investigation, presence of competing etiologies, or truly unidentified cause despite an 
extensive investigation.17 The NORSTROKE registry contains information on the 
TOAST classification. Table 7 shows TOAST etiology among patients with ACI 
confirmed by DWI-MRI admitted from 2006-2013, but also separately for patients 
with MACI and SACI.  




The role of cardiogenic embolism 
Even though the TOAST definition of cardiogenic embolism (CE) states that the 
evidence of the multiple arterial territory distribution of ischemic lesions supports the 
clinical diagnosis of CE, many of these patients end up in the category of 
undetermined etiology (UE). 
In Paper-I, 34 patients were diagnosed with UE even though CE was probable, either 
due to the presence of MACI in all three arterial territories, or due to other factors 
associated with CE, such as supraventricular tachycardia, palpitations, left bundle 
branch block or no concomitant ICA stenosis (Table 7). In Paper-III, the symptoms 
and clinical characteristics highly suggestive of CE were considered determinative. CE 
was strongly associated with MACI (53% vs. 28%; P<0001) and as a consequence, the 
UE subtype decreased substantially (42% vs. 32%; P<0.004).152 This change was 
accidentally not reported in the methodology section of the Paper-III. Nevertheless, 
neither CE- nor UE-subtype was included as an adjustment variable to the final 
analysis. Thus, this change had no implication for the final results. 
A recently published study evaluating clinical characteristics of patients with 
cryptogenic stroke and proven paroxysmal AF showed that bihemispheric distribution 
of the ischemic lesions was significantly associated with the detection of pAF (30% vs. 
5.5%).159 These data and our results support that the TOAST classification is 
insufficient for the correct diagnosis among patients with MACI. Possibly, other 
preferably phenotypic classifications should be used in these patients. Possibly, MACI 













Table 7. TOAST etiology in the NORSTROKE registry (2006-2013) 
TOAST All ACI 




N = 187 
MACI 
(Original TOAST) 
N = 187 
SACI 
N = 1938 
CE, N (%) 660 (31.1) 101 (54.0) 67 (35.8) 559 (28.8) 
LAA, N (%) 272 (12.8) 19 (10.2) 19 (10.2) 253 (13.1) 
SVD, N (%) 285 (13.4) 7 (3.7) 7 (3.7) 278 (14.3) 
OD, N (%) 68 (3.2) 6 (3.2) 6 (3.2) 62 (3.2) 
UE, N (%) 840 (39.5) 54 (28.9) 88 (47.1) 786 (40.6) 
*MACI (Modified TOAST) – etiological spectrum of MACI based on TOAST criteria, where the MACI 
and other clinical characteristics associated with CE were decisive factors; MACI (Original TOAST) - 
etiological spectrum of MACI based solely on TOAST criteria; LAA – large artery atherosclerosis; CE 
– cardiogenic embolism; SVD – small vessel disease;, OD – other disease; UE – undetermined 
etiology; MACI – Acute cerebral infarct(s) in a multiple arterial territories; SACI - Acute cerebral 
infarct(s) in a single arterial territory; ACI – acute cerebral infarct 
 
Our analyses support that CE is probably the leading etiology among patients with 
MACI. These findings appear to be in line with other studies. Akhtar et al recently 
published a simple literature-based pooled analysis where they sought to clarify the 
etiological spectrum among patients with MACI (Table 8). Unfortunately, the authors 
do not list which studies where included in the analysis and it is probable that the 
results may be influenced by the inconsistent methodologies.47 However, this is the 
biggest pooled analyses on this topic published to this date. The rate of CE was similar 
to our results in Paper-I (35.8% vs. 37.5%).145  
 
Table 8. The etiological spectrum of patients with MACI - pooled analysis 
Etiology Patients with MACI 
N=1715 
Cardiogenic embolism 638 (37.5) 
Large artery atherosclerosis 440 (25.7) 
Intracranial atherosclerosis 30 (1.8) 
Blood disorders and cancer 36 (2.1) 
More concomitant etiologies  44 (2.6) 
Undetermined 472 (27.6) 
Autoimmune diseases 3 (0.2) 
Iatrogenic / peri-procedural 2 (0.1) 
Adapted from Akhater et al 2019; MACI – Acute cerebral infarct(s) in multiple arterial territories  
 




Atrial fibrillation (AF) probably plays a central role in CE-associated MACI. Among 
67 MACI patients with CE, 85% had concomitant AF. On the other hand, 69% of 
patients with SACI diagnosed with CE had concomitant AF. There is an uncertainty of 
possible additional patients with paroxysmal AF (pAF), who were not revealed at 
discharge. There is evidence that up to 30% of all patients with cryptogenic stroke 
have pAF. Other modalities of long-term ECG monitoring, such as insertable cardiac 
monitoring (ICM), are superior to conventional follow-up with 24- or 48- hours 
Holter-monitoring. In our cohort, no patient was followed-up with ICM or other long-
term ECG monitoring device. This may have led to underestimation of pAF in our 
cohort. New, non-invasive devices utilized for long-term ECG monitoring, such as 
smartwatches may be a widely available and promising approach for the screening of 
high-risk population, with a possible impact on early primary and secondary 
prevention.132  
Other specific causes of CE, such as myocardial infarction or intramural cardiac 
thrombus, were grouped as CE and not selectively registered in the NORSTROKE 
database. Therefore, our results cannot provide data on other concrete causes of CE. 
Most of the patients in the category of CE had mostly cortical lesions on follow-up 
DWI-MRI. This finding underlines the importance of ischemic lesion patterns in 
diagnostic considerations (Table 9).  
Table 9. DWI-MRI patterns and TOAST classification among patients with 
MACI  
 TOAST  












Lacunar, N (%) 1 (4.8) 4 (19.1) 4 (19.1) 1 (4.8) 11 (52.4) 23 (7.4) 
Cortical, N (%) 3 (4.2) 50 (70.4) 0 (0) 2 (2.8) 16 (22.5) 71 (22.8) 
Subcortical, N (%) 0 (0) 5 (31.3) 0 (0) 0 (0) 11 (68.8) 15 (4.8) 
Mixed, N (%) 14 (7.5) 101 
(54.0) 
5 (2.7) 5 (2.7) 62 (33.2) 187 (60.2) 
Watershed, N (%) 7 (46.7) 4 (26.7) 0 (0) 1 (6.7) 3 (20) 15 (4.8) 
*The Bergen NORSTROKE registry (2006-2016) – not published  
LAA – large artery atherosclerosis, CE – cardiogenic embolism, SVD – small vessel disease, OD – 
other disease, UE – undetermined etiology, TOAST - the Trial of ORG 10172 in Acute Stroke 
Treatment; MACI – Acute cerebral infarct(s) in multiple arterial territories 




The role of large artery atherosclerosis 
Among patients with MACI, the TOAST diagnosis - large artery atherosclerosis 
(LAA) had similar occurrence as in patients with SACI (10.2 vs. 13.1).145 However, 
the presence of symptomatic ICA stenosis appeared to be significantly associated with 
MACI in both univariate and multivariate analyses. The LAA subtype includes ICA 
occlusions but it is often difficult to say if the occlusion is of CE or LAA origin. 
However, proximal ICA occlusions are more often caused by LAA. Whereas distal 
ICA occlusions are more likely caused by CE.  
Technically, a unilateral symptomatic ICA stenosis hardly causes MACI. So bilateral 
presence of ICA stenosis seems to be a prerequisite as it is shown in the Paper-II. It is 
possible that in some of these patients, the anatomic variations of the cerebral arteries, 
including fetal PCA (fPCA) or azygos ACA contribute. To our knowledge, there are 
no available data on the exact number of such patients. Reviewing brain imaging in 
our cohort of MACI patients, we also assessed the presence of the anatomic variations 
and possible connection to the mechanism of MACI. These data show that 79 out of 
311 patients (25.4%) had either bilateral or unilateral fPCA. There were 8 patients 
(2.6%) where fPCA had configuration corresponding with the distribution MACI. 
Azygos ACA was present in 14 patients (4.5%), but in only four patients (1.2%), 
MACI could potentially be attributed to this AV. In only one patient with unilateral 
ICA occlusion, we could assume that cross-flow mechanism was the mechanism 
behind MACI. These findings show that such AVs probably are rare contributors to 
MACI.  Other studies have not proven that fPCA may be a risk factor for TIA or CI.160 
An CT- or MR-angiography as a part of the diagnostic work-up, may exclude this less 
common mechanism of MACI. The MRI pattern of ischemic lesions may also predict 
the true etiology of MACI. Uni- or bilateral watershed cerebral infarcts may be caused 
by hypoperfusion either of cardiac origin or due to aggravation of an ipsilateral large 
artery stenosis, or by embolism from vulnerable, unstable or ruptured atherosclerotic 
stenosis. In our cohort of MACI patients, 15 (4.8%) patients had watershed infarcts, of 
which 7 (46.7%) were categorized as LAA (Table 9).  
 




The role of small vessel disease  
Based on our results and other studies, small vessel disease (SVD) probably causes a 
minority of MACI. Only 7 patients (3.7%) had distribution of lacunar infarcts in 
multiple territories accompanied by risk factors characteristic for SVD (Table 7). In 
the NORSTROKE registry, patients with lacunar MACI were mostly categorized as 
UE subtype (52.4%). This indicates that coexistence of etiologies or risk factors 
suggesting also CE or LAA, may contribute to lacunar MACI in these patients (Table 
9).100 On the other hand, we must distinguish lacunar MACI from multiple lacunar 
infarcts within only one arterial territory, which may be a sign of a severe generalized 
SVD.103 
Except for common risk factors among patients suffering lacunar stroke, such as 
hypertension, hypercholesterolemia or DM, the extent of leukoaraiosis usually reflects 
how pronounced ongoing SVD is.23 
In the NORSTROKE registry, leukoaraiosis seen on MRI was significantly more 
common among patients with MACI compared to the patients with SACI (67% vs. 
56%; P<000.1), which may be also result of the overall older MACI population. 
Interestingly, patients with MACI who were diagnosed with SVD subtype had similar 
level of leukoaraiosis compared to patients with SACI who were classified with SVD 
subtype (65.5% vs. 55.6%; P=0.537). This may again support a multifactorial 
pathophysiology in lacunar MACI rather than pure SVD in these patients.  
 
The role of rare etiologies 
Based on the TOAST classification, rare etiologies are categorized as other diseases 
(OD) subtype.  We found no difference between SACI and MACI (3.2% vs. 3.2%; 
P=0.97) regarding OD-patients in our cohort. One of the less common etiologies is 
hypercoagulable state associated with an active cancer (Trousseau syndrome). We 
performed a sub-analysis using the data from the PhD work of Dr. Aurora Selvik, who 
reviewed admission records of all stroke patients in the NORSTROKE registry 
admitted from 2006 to 2013 and extracted all cancer diagnoses.161 Results were 
presented at the European Stroke Organization Conference (ESOC) 2018 in Goteborg 
(Figure 6).162 We found that the presence of active cancer (cancer diagnosed ±6 




months from the index stroke) was significantly more common among patients with 
MACI compared to patients with SACI (12% vs. 2%; P<001). The MACI patients had 
a significantly higher median of D-Dimer on admission [7.1 (IQR=2.7-20) vs. 0.9 
(IQR=0.5-2.1); P<0.001]. High values of D-Dimer correspond with the fact that most 
of these patients had mucinous types of cancer, including lung, colon or pancreas 
cancer, which often are associated with hypercoagulable states.163 Our findings also 
indicate that the cancer-associated hypercoagulable state is associated rather with 
MACI than SACI. It is unknown if some of these patients had nonbacterial thrombotic 
endocarditis, which often requires TEE for correct diagnosis. It may be difficult to 
differentiate AF-associated MACI from cancer-associated MACI based on standard 
diagnostic work-up. One study concluded that patients with cancer-associated MACI 
often have D-Dimer > 2.0 μg/mL, which remains high also in the subacute phase.118  
We have no further data on other rare etiologies or concomitant diseases potentially 
associated with hypercoagulable states.  
 
Figure 6. Active cancer in patients with MACI and SACI 
 
*Adapted from the poster Novotny et al. 2018 (ESOC 2018; Gothenburg) 
MACI – Acute cerebral infarct(s) in multiple arterial territories; SACI - Acute cerebral infarct(s) in a 
single arterial territory 
 
The time-pattern and etiology 
As we have shown in Paper-II, cerebral embolization in LAA-associated MACI occurs 
most probably successively over time. The ischemic lesions may be separated by hours 
or even days as the blood clots or their fragments are released one by one from the 




atherosclerotic plaques. In contrast to this, the ischemic lesions in the CE-associated 
MACI most likely occur simultaneously as a sudden shower of emboli with no 
additional embolization the following days after symptom onset. One of the 
explanations for this phenomenon may be the morphology of atherosclerotic plaque in 
symptomatic ICA stenoses. Several studies have shown that atherosclerotic plaques in 
the symptomatic ICA are associated with increased neovascularization, fibrous cap 
thinning, inflammation, plaque necrosis and rupture.164, 165 All these factors define 
instability and vulnerability of the atherosclerotic plaques. Therefore, the plaques are 
prone to recurrent embolization, mainly during the acute phase, when the plaque is 
unstable. Ongoing embolization not only leads to a higher total risk of recurrence, but 
also leads to a higher risk of recurrence within the first 30 days.139, 166  
In Paper-II, we also conducted a sub-analysis aiming at patients with MACI solely in 
the anterior circulation and with concomitant symptomatic or asymptomatic ICA 
stenosis. In the cohort of patients with MACI in the anterior circulation only (N=93), 
there were 25 patients with ICA stenosis, all of them had symptomatic ICA stenosis on 
at least one side, and no patient had only asymptomatic ICA stenosis(es). This 
suggests possible importance of plaque instability but also its bilateral presence in 
these patients. It is probable that the presence of an unstable plaque bilaterally is a 
prerequisite for MACI. The morphology and stability of the atherosclerotic plaques 
may be evaluated non-invasively. Advanced neurosonology, including 3D ultrasound 
and contrast-enhanced ultrasound imaging may clarify in detail plaque shape and size, 
but also the degree of intra-plaque neovascularization and hemorrhage.167, 168 
Morphology and neovascularization may also be evaluated by high-resolution 
contrast-enhanced MRI with higher field strength (Tesla).169 Microemboli detection 
has also been shown as an effective and non-invasive approach to evaluate on-going 
embolization. Silent microembolization after stroke is more common in patients with 
symptomatic ICA stenosis accompanied by ulcerative plaques.170, 171 Silent 
microembolization in the acute phase is also associated with a higher risk of recurrent 
stroke.172, 173 These findings may support the theory of successive embolization in 
LAA-associated MACI, as shown in our results. The presence of microembolization 
may lead to adjustment or change of inadequate secondary prevention and, thus, 
preventing recurrent ischemic events in these patients.  




Table 10 shows that patients with LAA-associated MACI underwent follow-up MRI 
later than those with CE-associated MACI. Patients with MACI and concomitant 
symptomatic or asymptomatic ICA stenosis, regardless of the TOAST category, also 
underwent MRI later than those with CE-associated MACI. On the other hand, there 
was no difference between patients with CE- and LAA-associated SACI (P=0.565). It 
is not clear why MRI was taken later in patients with LAA-associated MACI and we 
do not have data which can explain this phenomenon directly. It is possible that in 
patients with LAA-associated MACI, the atherosclerotic plaques are more unstable 
bilaterally than in those with LAA-associated SACI. These patients might have a 
minor or transient neurological deficit hours or days before the admission, which was 
by the patient ignored and a second, major deficit could be the reason for a later 
admittance relatively to the initial minor neurological event. The evolution of DWI-
MRI and ADC-MRI changes is gradual and follows a certain time-course during 
hyper-acute, acute and chronic stage of CI.174, 175 However, it is difficult to 
differentiate the age of the lesions based on one single DWI-MRI. We therefore cannot 
confirm that all patients categorized as MACI had all their ischemic lesions truly acute 
in relation to each other in terms of hours.    
 
Table 10. Time from stroke onset to follow-up MRI (days) 
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  P=0.008   
SACI 
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  P=0.565   
 
Comparison of time (days) from stroke onset to MRI within CE and LAA subgroup as well as in 
patients with either symptomatic ICAS or asymptomatic ICAS regardless of TOAST classification 
MACI – Acute cerebral infarct(s) in multiple arterial territories; SACI - Acute cerebral infarct(s) in a 
single arterial territory; CE – cardiogenic embolism; LAA – large arthery atherosclerosis; ICAS – 




internal carotid artery stenosis; MRI – magnetic resonance imaging; IQR – interquartile range; SD – 
standard deviation  
 
Clinical manifestation may be misleading 
The brain is extremely complex and knowledge of its topographical function is 
paramount to set a correct diagnosis in an acute setting. This mainly applies to the 
neurological disorders craving prompt therapeutic decision-making. Stroke is the field 
of acute neurology comprising the highest number of such patients. In suspected CI 
without visible vascular occlusion on vascular imaging, the clinician must rely solely 
on her/his diagnostic skill and experience in order to initiate prompt IVT and to 
exclude other differential diagnoses. Patients with MACI are characterized by 
involvement of at least two distinct arterial territories simultaneously. Therefore, the 
patients may present with unusual clinical manifestation than in patients with SACI. 
One may expect a higher frequency of bilateral neurological deficits or bi- / unilateral 
neurological deficits in combination with the symptoms from functional areas supplied 
by the posterior circulation. However, the ischemic lesions in MACI are often 
heterogeneous in size, number and distribution. These factors together with coexisting 
comorbidities may influence the final clinical manifestation. A standard initial 
neurological assessment is usually performed by NIHSS, which represents a widely 
used assessment scale of clinical severity of a stroke.147 NIHSS has high reliability and 
validity. It may predict the clinical outcome and has been used in numerous clinical 
trials for acute stroke.176 However, some aspects of NIHSS has been challenged for its 
inaccuracy. Several studies showed that NIHSS favors the left, in most cases, 
dominant hemisphere, over the right, usually non-dominant, despite similar lesion 
volumes.177, 178 An analysis of a large German hospital-based registry comprising 
20.097 stroke patients showed an unequal distribution of left- and right hemisphere 
stroke (56% vs. 44%, P<0.0001).179 These differences applied for CI, but not for ICH. 
The difference also diminished with increasing severity of the stroke, as the 
probability of symptom recognition then is higher, regardless of the side of the stroke. 
The fact that there was no difference between left and right-sided ICH also 
corresponds with generally more severe neurological deficit independently of the 
affected side. Right hemisphere lesions are associated with neglect and thus decreased 
awareness of the symptoms also by the patient. Similarly decreased recognition of 




such symptoms may also apply for the first-line physician. Two studies reported 
around 15% higher occurrence of silent strokes in the right hemisphere.180, 181 It is 
therefore not by chance that patients with ACI in the left hemisphere are more 
frequently treated with tPA, and also more frequently admitted within the first 3 hours 
after symptom onset.182   
From a clinical point of view, MACI are interesting model to study. Based on the 
admission records, only 89 out of 311 patients with MACI (28.8%) admitted to 
Haukeland University Hospital presented with clinical manifestation corresponding to 
the involvement of more than one arterial territory. Looking separately at patients with 
MACI in only the anterior circulation (N=133), left-hemisphere symptoms were more 
often described in the admission records (43.6 vs. 28.6%). Our analyses showed that a 
lesion in the left arterial territory is associated with single-territory clinical 
manifestation (OR=0.37, 95% CI=0.16-0.82). This again emphasizes an 
underestimation of right-hemisphere stroke symptoms. The left-hemisphere symptoms 
give more prominent and more recognizable neurological deficits and may shadow the 
right-hemisphere symptoms. A paresis in the dominant extremity or aphasia may 
easily pull the attention of both patient and examining physician from other, 
sometimes hardly recognizable forms of cognitive deficit, as apraxia or neglect.  
Neglect may be unrecognized by both patient and examining physician. However, 
NIHSS itself underestimates the clinical manifestation from the right-hemisphere. It is 
possible to assign only 2 points to the neglect compared to 7 points to the deficit in the 
language. 
Interestingly, an involvement of all three arterial territories (N=73) seemed increased 
the recognition of the right-hemisphere symptoms. It is unclear if concomitant 
symptoms originating from the functional areas supplied by posterior circulation may 
increase attention towards the right-hemisphere symptoms.  
Another drawback of NIHSS is its limitation in recognition of stroke in the posterior 
circulation compared to the anterior one.183 The issue mainly is an underestimation of 
posterior stroke severity. Sato et al. showed that patients with CI in the posterior 
circulation have a higher probability of unfavorable outcome at three months despite 
relatively low NIHSS compared to the CI in the anterior circulation. The proposed 




NIHSS cut-off predicting favorable outcome in posterior circulation CI was therefore 
estimated to ≤4-5 compared to ≤8 for anterior circulation CI. 183, 184 Our study showed 
that in patients with MACI and involvement of the posterior circulation, symptoms 
from the posterior circulation were recognized almost uniformly in 50% of cases. It 
may be sometimes challenging to distinguish if the ischemic lesion lies in the anterior 
or posterior circulation since the symptomatology may be overlapping. In general, 
symptoms from posterior circulation are less often recognized and follow-up 
neuroimaging is essential for final confirmation and accurate localization of the 
lesions.185 Our findings indicate that without MRI, majority of MACI would be barely 
diagnosed based on the initial clinical manifestation only.   
 
The burden of MACI 
In general, patients with TIA or CI are at a higher short- and long-term risk for 
complications and readmission during stroke recovery.186-188 Infections and recurrent 
vascular events are the most common complications. An increased presence of 
comorbidities in these patients may further worsen the outcome. We analyzed patients 
with MACI as a separate entity and compared the course of in-hospital stay to patients 
with SACI.  
In the Bergen NORSTROKE registry, the overall frequency of patients experiencing 
one or more in-hospital complications, as defined in Paper-III, was 36.1%. Other 
studies have reported frequencies of in-hospital complications in a range from 25.2% 
to 59%. 189-192 The frequency and types of these complications are also strongly related 
to stroke subtype, severity and localization.193 However, different methodologies and 
different sets of studied complications make comparison difficult.  
Table 11 shows the distribution of in-hospital complications in the two groups. 
Patients in the MACI group experienced more complications in total (51 % vs. 36%; 
P<0.001). Based on univariate analyses, several complications appeared to be more 
frequent in the MACI group, including deep venous thrombosis (DVT), myocardial 
infarction (MI), symptomatic intracranial hemorrhage, epileptic seizure, pneumonia, 
urinary tract infection, urinary retention and urinary incontinence. However, in the 




multivariate analysis, only DVT, MI and any complication remained significantly 
more frequent in the MACI group.22 
 






Any complication, N (%)  159 (51.1) 1049 (35.6) <0.001 
Deep venous thrombosis, N (%) 4 (1.3) 4 (0.1) <0.001 
Cerebral infarction, N (%) 1 (0.3) 15 (0.5) 0.672 
Myocardial infarction, N (%) 10 (3.2) 28 (0.9) <0.001 
Pulmonary embolism, N (%) 3 (1.0) 11 (0.4) 0.118 
Symptomatic ICH, N (%) 7 (2.3) 14 (0.5) <0.001 
Heart failure, N (%) 6 (1.9) 26 (0.9) 0.065  
Epileptic seizure, N (%) 15 (4.8) 85 (2.8) 0.047 
Pneumonia, N (%) 37 (11.9) 202 (6.7) 0.001 
Infection with unknown focus, N (%) 7 (2.3) 31 (1.0) 0.052 
Urinary tract infection, N (%) 53 (17.0) 357 (11.8) 0.007 
Urinary retention, N (%) 78 (25.1) 529 (17.4) 0.001 
Urinary incontinence, N (%) 50 (16.3) 304 (10.7) 0.003 
Depression, N (%) 19 (6.1) 161 (5.3) 0.552 
Death, N (%)   5 (1.6) 21 (0.7) 0.080 
MACI – Acute cerebral infarct(s) in multiple arterial territories; SACI - Acute cerebral infarct(s) in a 
single arterial territory; ICH – intracranial hemorrhage 
 
DVT during in the first seven days of in-hospital stay was registered in 8 out of 3343 
(0.24%) patients regardless of the lesion distribution. This rate is in line with other 
studies.191 However, four of these patients had MACI (P=0.017). We hypothesized that 
concomitant comorbidity might contribute to the higher occurrence of DVT in the 
MACI group. It is well known that some malignancies are associated with a 
hypercoagulable state (Trousseau syndrome). This syndrome is associated with a 
higher risk for thromboembolism in general, including CI or venous 
thromboembolism.194 Our data, and also other studies, show a higher occurrence of 
MACI among the cancer patients115, 162 and the same applies for pulmonary embolism 
and DVT.195, 196 We therefore performed a sub-analysis on concomitant cancer in 
patients experiencing DVT (supplement of Paper-III). All four patients having MACI 
and DVT during hospitalization also had active cancer. One of these patients had 




cancer accompanied by a catastrophic antiphospholipid syndrome. These patients have 
often resistant hypercoagulable states, which makes the secondary prevention of 
recurrent embolism challenging or ineffective. The four patients in the SACI group 
experiencing DVT had no cancer but experienced a more severe stroke than patients 
with MACI and DVT, as confirmed by the higher median NIHSS on admission (13 
[IQR=7-16.5] vs. 1 [IQR=0-4]). It is possible that in these patients, the DVT was 
mainly associated with reduced post-stroke mobility during the first days of 
hospitalization. The confidence interval for DVT in the analysis was rather wide, and 
this is related to the small sample size. However, these findings suggest that 
concomitant DVT and MACI should always work as a warning sign and cancer 
screening should be considered in these patients.  
MI was more frequent in the MACI group (3.2% vs. 0.9%). An explanation may be a 
higher occurrence of atrial fibrillation (AF). AF is associated with an increased risk of 
MI independent of common coronary heart disease risk factors.197 We therefore 
performed a sub-analysis of patients experiencing MI during hospitalization who had 
or were diagnosed with concomitant AF (supplement of Paper-III). We found that 70% 
of patients with MACI and MI had concomitant AF, in contrast to only 32% in the 
SACI group. In other studies, the risk of MI after stroke is 2.3% per year (95% CI, 1.6 
to 2.9).198 In our registry, more than 3% of MACI patients experienced MI in the first 
week after the index stroke. The relationship between MI and AF is not clear. It is 
possible that AF is not a direct risk factor for MI, but rather a marker for existing 
coronary heart disease. Pure coronary embolism related to AF is considered rare. It is 
attributed to the mutual constitution between coronary arteries and aorta. Up to 12% of 
MI is caused by coronary embolism, of which 24% are attributed to AF.199 Another 
explanation may be a type 2 MI caused by a non-coronary trigger in the absence of 
acute plaque disruption. Some patients with AF may experience poorly controlled 
ventricular response followed by oxygen supply-demand mismatch and consequently 
myocardial ischemia.197, 200 
Our findings indicate that both DVT and MI most likely are related to the underlying 
malignancy or AF/heart disease respectively. On the other hand, the complications 
among the patients with MACI, which appeared to be more frequent in the univariate 




analysis, may be mainly related to higher age, worse functional status before the index 
stroke, or stroke severity itself.  
Death within the first seven days of in-hospital stay did not differ significantly 
between MACI and SACI patients. This result may, however, be biased. Some patients 
died within 24 hours after admission before the MRI scan was taken. Moreover, in 
some patients with poor prognosis, MRI was not performed. These patients (N=634) 
were examined only with CT scan and were therefore not included in the analysis. An 
autopsy was not performed in the vast majority of our patients. Thus, the frequency of 
additional MACI patients is unknown. It is possible that this group comprised a 
considerable number of patients with MACI. 
All of these factors may have contributed to the overall worse early clinical and 
functional outcome (Table 12). Our study confirms that MACI should be seen as a 
“red flag” not only in the diagnostic work-up but also in the follow-up during 
hospitalization.  
 
Table 12. NIHSS and mRS on admission and at day 7 / discharge.  
 MACI (N=311) SACI (N=3032) P-value 
NIHSS on admission 4 (1-9) 2 (2-5) <0.0001 
NIHSS at discharge 2 (1-7) 1 (0-4) <0.0001 
mRS prior admission 0 (0-2) 0 (0-0) 0.008 
mRS at discharge 3 (1-4) 2 (1-3) <0.001 
NIHSS- National Institutes of Health Stroke Scale; mRS - Modified Rankin Scale 
 
Impact of MACI on treatment 
There are no particular limitations in acute reperfusion therapy for patients with 
MACI. Our findings show no significant difference in the frequency of intravenous 
thrombolysis (IVT) between patients with MACI and SACI (23.5 vs. 19.5; P=0.09). 
Patients with MACI received, however, more often mechanical thrombectomy (MT) 
(10.1% vs. 2.6; p=<0.001) (Supplement Paper-III). Overall more severe stroke in the 
MACI group may be related to a higher occurrence of large vessel oclusions (LVO). 
Patients with MACI who received IVT had a higher median NIHSS on admission 
compared to the patients with SACI (8 [IQR=4-14] vs. 5 [IQR=3-11] P=0.007). A 




similar trend applies for MACI patients who underwent MT (17 [IQR=10-20] vs. 13.5 
[IQR=6.5-19.5; P=0.185]. The severity of stroke probably represents a critical factor in 
therapeutic decision-making in regard to acute reperfusion therapy.  
As shown in the supplement of Paper-III, the patients with MACI were more often 
anticoagulated prior to the index stroke. This corresponds with the higher frequency of 
known paroxysmal and chronical AF before admission. This pattern is also reflected in 
the secondary prevention introduced during hospitalization or after discharge. Almost 
twice as many patients in the MACI group were discharged with anticoagulation 
compared to those having SACI (59.5% vs. 34.7%; <0.001), whereas antiplatelet and 
lipid-lowering therapy more often was introduced in patients with SACI. The 
etiological spectrum of MACI discussed in this dissertation is the explanation.  
Higher occurrence of rare forms of CE among patients with MACI, such as Trousseau 
syndrome, may require a different approach both in regards to acute reperfusion 
therapy and to secondary prevention.  
 
Strengths and limitations 
The Bergen NORSTROKE registry represents prospective study comprising a large 
number of well-described stroke patients, of which the majority was examined by 
MRI. To our knowledge, there have not been published any studies with a comparable 
number of patients with DWI-MRI confirmed MACI.  
There are, however, several limitations to this study. Not all stroke patients underwent 
complete investigation. Even though our results show that cardiogenic embolism, 
predominantly atrial fibrillation, is the major cause of MACI, this etiology may be 
underestimated. If standard ECG or Holter-monitoring did not reveal AF, further 
investigation was not performed. Long-term cardiac monitoring would probably reveal 
more cases of AF or relevant arrhythmias, predominantly in patients with MACI. It is 
possible that more extensive echocardiographic examination would reveal a higher 
number of cardiac emboli sources as well. It applies, for example, to nonbacterial 
thrombotic endocarditis, which often requires confirmation by TEE. The TOAST 
classification has several drawbacks in the form of over- or underestimation of some 




TOAST categories. Following the strict TOAST criteria, many patients often end up in 
the undetermined etiology subtype. 
One of the limitations in Paper-III and Paper-IV is the lack of data on lesion volumes 
which could influence the results in both papers. This issue was pointed out in the two 
comments to the paper-III.201, 202 The importance of lesion volume may, however, be 
misleading in case of MACI. It is possible that some patients with MACI had worse 
outcome despite low lesion volume. A concomitant lesion in vital or important 
functional brain areas such as brain stem or capsula interna may be an example.203 
Conclusions and implications 
Patients with MACI represent a substantial portion of the stroke population which 
every stroke physician encounter in clinical practice. However, few studies have been 
published on this topic. With our four papers, we contribute to clarify some etiological, 
clinical and diagnostic aspects of this specific group of stroke patients.  
I. We confirmed that MACI are not a rare phenomenon and represents 
approximately 10% of ischemic stroke patients consecutively admitted to 
our stroke unit. We may also conclude that cardiogenic embolism subtype is 
the major TOAST category among MACI and AF the primary etiology. 
However, presence of symptomatic ICA stenosis appeared to be associated 
with MACI and is probably an additional risk factor. In these patients, 
bilateral atherosclerotic plaque instability is probably a prerequisite. In a 
substantial part of MACI classified as unknown etiology subtype, the 
cardiogenic embolism (CE) subtype was highly probable due to distribution 
of the lesions in all three territories, absence of ICA stenosis and 
concomitant clinical characteristics suggesting CE instead. This finding 
shows that TOAST classification may underestimate CE-subtype among 
MACI to a large extent. Other rare etiologies of stroke, such as cancer, 
should always be considered in these patients. MACI occurs relatively more 
often in females, which may be related to a higher risk of CI in females 
having atrial fibrillation. The frequency of MACI increases with age, which 
is in line with an increasing occurrence of comorbidities, such as atrial 




fibrillation or atherosclerosis. Patients with MACI have higher NIHSS on 
admission, indicating more severe strokes in this stroke group.  
II. We showed that the time from clinical onset to the first MRI imaging may 
shed light on the etiology of MACI. We found a positive correlation 
between the time from the stroke onset to DWI-MRI and the frequency of 
LAA-associated MACI. We also found a positive correlation in patients 
having asymptomatic and symptomatic ICA stenosis regardless of TOAST 
classification. The same patterns apply for MACI limited to only anterior 
circulation. There was no correlation between the time from stroke onset to 
DWI-MRI and the frequency of CE-associated MACI. Our results indicate 
that emboli originating from ICA stenosis are probably loosened 
successively in step-wise time pattern. This may be related to the unstable 
character of atherosclerotic plaques bilaterally in the acute phase after the 
stroke onset. CTA or MRA should be performed in all patients with MACI 
to exclude arterial variation associated mechanism. On the other hand, 
emboli from the heart are probably loosened rather concurrently as a shower 
of emboli. The single episode is probably not followed by any additional 
embolization in the nearest days after the stroke. We therefor suggest that 
microemboli detection should be considered in LAA-associated MACI to 
assess the effectiveness of secondary prevention of stroke recurrence. 
III. We found that during the first seven days of the in-hospital stay, patients 
with MACI, do worse than those with SACI. Deep venous thrombosis 
(DVT) and myocardial infarction (MI) occur more often in the MACI group. 
This may be related to the concomitant comorbidities or etiology of the 
MACI itself. All MACI patients experiencing DVT also had cancer 
diagnosed within 6 months from the index stroke. Thus, on-going Trousseau 
syndrome may be a plausible explanation for thromboembolism. The 
association between MACI and MI may be explained by the higher 
frequency of AF, which has been shown as a risk factor for MI. Both short-
term clinical and functional outcome appeared to be worse in the MACI 
group. Higher frequency of complications, more severe stroke, higher age or 
worse functional status before the admission among the patients diagnosed 




with MACI may explain these findings. We believe that tight early follow-
up and extensive diagnostic work-up in these patients may reduce some of 
these complications and prevent negative progression. 
IV. We showed that more than 70% of patients diagnosed with MACI on DWI-
MRI present with a single-territory clinical manifestation (MACI-S). 
MACI-S was associated with less than five ischemic lesions in total, 
involvement of the left arterial territory and partial anterior circulation 
infarct clinical stroke syndrome (PACI) as defined by the OCSP 
classification. Multi-territory clinical manifestation was associated with 
more than 10 ischemic lesions in total, involvement of all three territories 
and total anterior circulation infarct clinical stroke syndrome (TACI) as 
defined by the OCSP classification. We assume that the overweight of 
MACI-S may be explained by several factors. First, NIHSS fails to 
sufficiently recognize clinical manifestation from the right anterior and 
posterior territory. Second, some of the acute ischemic lesions might be 
clinically silent and right hemisphere symptoms may be overshadowed by 
more striking symptoms from the left hemisphere. Our findings emphasize 
the importance of DWI-MRI imaging for the final diagnosis of MACI in the 
acute phase, facilitating the further diagnostic and therapeutic decision-
making process in these patients.     
We believe that MACI should be seen as a “red flag” in stroke medicine. Our results 
showed that MACI are not rare and differ from SACI in many clinical aspects, 
including etiology, pathophysiology, clinical manifestation and early outcome. Thus, 
patients with MACI require a different diagnostic and therapeutic approaches. We 
believe that this dissertation and associated papers will contribute with additional and 
useful knowledge which may be applied in the daily practice.  
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Acute cerebral infarcts in multiple arterial
territories associated with cardioembolism
Novotny V, Thomassen L, Waje-Andreassen U, Naess H. Acute
cerebral infarcts in multiple arterial territories associated with
cardioembolism.
Acta Neurol Scand: DOI: 10.1111/ane.12606.
© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Objectives – It is generally believed that cardioembolism is the main
cause of multiple acute cerebral infarcts (MACI). However, there are
surprisingly few DWI studies and results are conflicting. Based on a
large prospective study we hypothesized that MACI are associated
with cardioembolism. Materials and methods – We studied 2697
patients with acute cerebral infarcts between February 2006 and
October 2013 who were prospectively registered in The Bergen
NORSTROKE Registry. Among them, 2220 (82.3%) patients
underwent magnetic resonance imaging (MRI) and 2125 (96%) of
these 2220 patients had DWI lesions. Only patients with DWI lesions
were included. MACI were defined as at least two DWI lesions in at
least two different arterial territories. Results – MACI were detected
in 187/2125 (8.8%) patients with DWI lesions. MACI patients were
older and more often females. MACI were associated with
cardioembolism (P = 0.042), especially atrial fibrillation (P = 0.002).
Other associations were symptomatic internal carotid artery (ICA)
stenosis (P = 0.014), asymptomatic ICA stenosis (P = 0.036), and
higher NIHSS score on admission (P < 0.001). Among patients with
no cardioembolism, 34 (35%) with MACI had symptomatic ICA
stenosis versus 268 (25.0%) with non-MACI (P = 0.037); 20 (20%)
with MACI had asymptomatic ICA stenosis versus 134 (13%) with
non-MACI (P = 0.031). In the logistic regression analysis, cardiac
embolism and symptomatic ICA stenosis were independently
associated with MACI. Conclusions – Acute cerebral infarcts in more
than one arterial territory occur among almost 10% of the patients
and are associated with cardioembolism.
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Introduction
The etiology of cerebral infarcts must be deter-
mined to prevent recurrence. Diffusion weighted
imaging (DWI) is sensitive to acute ischemic
lesions and valuable as to etiologic considerations
(1, 2). For visualization of ischemic lesions within
the first hour after the onset of symptoms, DWI
is the optimal modality. Furthermore, it allows
differentiation between acute and chronic lesions
in most cases (3, 4). Some patients have multiple
acute cerebral infarcts (MACI) occurring in more
than one arterial territory. This suggests that
MACI represent embolic mechanism and stroke
neurologists generally believe that cardioem-
bolism (CE) is often the main cause besides other
potential sources of embolism, for example, from
the aorta, major extracranial and intracranial
vessels, fetal type of PCA or due to cross-flow
mechanism, coagulation disturbances, hyperho-
mocysteinemia, etc. (3, 5, 6). However, the num-
ber of DWI-based studies supporting this concept
is surprisingly low, and previous results are con-
flicting (7). Furthermore, most studies have used
different methods and have been retrospective
with too small sample sizes (7, 8).
TOAST classification divides cardiac sources
into high-risk and medium-risk groups according
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to the probability of cardioembolic stroke. Evi-
dence of previous transitory ischemic attack
(TIA) or stroke in more than one vascular terri-
tory or systemic embolism supports a cardiogenic
mechanism (9). The mechanisms behind multiple
acute lesions in a single territory must be distin-
guished from those which occur in more than one
territory. Most multiple brain infarcts in a single
territory are probably caused by early fragmenta-
tion of one thrombus or embolus, whereas MACI
are probably caused by CE or ICA stenosis (3,
10). We present the data on MACI in a prospec-
tive study including a large number of patients.
We hypothesized that MACI are associated with
CE.
Materials and methods
All consecutive patients with acute ischemic
stroke (the index stroke) admitted to the Neu-
rovascular center, Department of Neurology,
Haukeland University Hospital between February
2006 and October 2013 were prospectively regis-
tered in The Bergen NORSTROKE Registry.
Ischemic stroke was defined in accordance with
the Baltimore-Washington Cooperative Young
Stroke Study Criteria comprising neurological
deficits lasting more than 24 hours because of
ischemic lesions or TIA where computer tomog-
raphy (CT) or MRI showed infarcts related to
the clinical findings (11). In this study, only
patients with DWI lesions were included.
CT was performed as soon as possible after
admission to the hospital. It was the routine of
our department to refer all patients with cerebral
infarction to MRI unless there were contrary rea-
sons such as pacemaker, none-consenting, or
unstable patient. DWI was performed as part of
a routine MRI protocol for stroke patients on 1.5
Tesla Siemens Magnetom (Symphony). The
DWI-sequence used was ep2d_diff_3scan_trace,
with the following specifications of parameters:
field of view (FOV) 230 mm, slice thickness 5
mm, TR 3200 ms, TE 94 ms. All CT and MRI
scans were reviewed by a neurologist (HN) with
long CT and MRI experience.
The National Institutes of Health Stroke Scale
(NIHSS) was used to assess stroke severity on
admission. Investigations included cerebral MRI
and CT, Holter monitoring, echocardiography,
and carotid duplex sonography. Isolated acute
ischemic lesions on DWI imaging were defined as
lacunar infarcts if <1.5 cm and located subcorti-
cal or in the brainstem (9). All other DWI lesions
were defined as non-lacunar possibly embolic
infarcts (12). ICA stenosis was defined as stenosis
>50% or occlusion based on duplex sonography
(13). Among patients with MACI, most patients
had neurologic deficits from only one of the
affected arterial territories. If the patient had
symptomatic ICA stenosis associated with ipsilat-
eral non-lacunar infarction, asymptomatic infarc-
tion in another territory and no high- or
medium-risk cardiac source, then atherosclerosis
was considered to be the cause.
Traditional risk factors were defined according
to a predefined protocol and included angina pec-
toris, myocardial infarcts, intermittent claudica-
tion, hypertension, diabetes mellitus, and smoking
(14, 15). Current smoking was defined as smoking
at least one cigarette per day. Diabetes mellitus
was considered present if the patient was on glu-
cose-lowering diet or medication. Hypertension,
angina pectoris, myocardial infarcts, and periph-
eral artery disease were considered present if diag-
nosed by a physician any time before stroke onset.
In addition, atrial fibrillation was registered. Atrial
fibrillation required electrocardiography (ECG)
confirmation any time prior to stroke onset or dur-
ing hospital stay and was categorized as paroxys-
mal atrial fibrillation or chronic atrial fibrillation
(16, 17). Etiology was determined by the Trial of
Org 10172 in Acute Stroke Treatment classifica-
tion (TOAST) and classified as large-artery
atherosclerosis, cardioembolism, small vessel dis-
ease, other, and unknown. CE was defined as a
sudden arterial occlusion due to embolus released
from heart because of high- or medium-risk
cardiac source. Large-artery atherosclerosis had to
be excluded as a probable cause (9).
MACI in different arterial territories were
defined as at least two DWI lesions in at least
two different arterial territories (right or left ante-
rior or posterior cerebral circulations) (18, 19).
The arterial territories in the anterior circulation
included anterior cerebral artery (ACA), the mid-
dle cerebral artery (MCA), the leptomeningeal
branches of the ACA, MCA, the anterior choroi-
dal artery (AchA), the perforating branches of
the ICA, AC
A, MCA, and the AchA. In the posterior circula-
tion, the vascular territories were vertebral arter-
ies, basilar artery, the superior cerebellar artery,
the anterior inferior cerebellar artery, the poste-
rior inferior cerebellar artery, and the posterior
cerebral artery (PCA) (20).
Chi-square test was used for categorical vari-
ables. For continuous variables, we used Stu-
dent’s t-test and Mann–Whitney U-test as
appropriate. Stepwise forward logistic regression
analyses were performed based on variables in
Table 1 as detailed in the Results. Lowess
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smoother curve was obtained for the relative fre-
quencies of MACI in relation to age. STATA
14.0 (StataCorp, College Station, Texas, USA)
was used for analyses.
The study was approved by the local ethics
committee (REK Vest).
Results
In total, 2697 patients had acute cerebral infarcts.
MRI including DWI imaging was performed in
2220 (82%) patients, and among these, 2125
(96%) had DWI lesions. MACI were detected in
187 (8.8%) patients. In total, 1058 patients
(49.8%) underwent Holter monitoring and parox-
ysmal atrial fibrillation was detected in 155
patients (14.7%). Among patients with MACI, 23
(12.4%) had known paroxysmal atrial fibrillation
and 18 (9.8%) had known chronic atrial fibrilla-
tion prior to the index stroke.
Table 1 shows demographics of MACI and
non-MACI patients. MACI patients were older
(P = 0.013) and more often females (P = 0.011).
MACI were associated with CE (P = 0.042),
atrial fibrillation (P = 0.002), symptomatic ICA
stenosis (P = 0.014), asymptomatic ICA stenosis
(P = 0.036), and higher NIHSS score on admis-
sion (P < 0.001).
Among patients with no CE according to
TOAST criteria, 34 (35%) with MACI had
symptomatic ICA stenosis versus 268 (25.0%)
with non-MACI (P = 0.037), and 20 (20%) with
MACI had asymptomatic ICA stenosis versus
134 (13%) with non-MACI (P = 0.031).
Figure 1 shows the relative frequency of MACI
according to age based on lower smoother func-
tion.
Table 2 shows the results of the final logistic
regression analysis with MACI versus non-MACI
as dependent variable and using independent
variables from Table 1 in a stepwise forward pro-
cedure. Age and sex were kept as independent
variables in all analyses. MACI were indepen-
dently associated with CE and symptomatic ICA
stenosis.
Table 1 Demographics of patients with acute cerebral infarctions in one or
two or more arterial territories among 2125 patients in the Bergen Stroke study
Two or three territories One territory
PN = 187 N = 1938
Age, years (SD*) 71.7 (14.0) 68.9 (14.7) 0.013
Female, n (%) 91 (48.7) 758 (39.1) 0.011
Male 96 (51.3) 1180 (60.9)
TOAST
Large-artery atherosclerosis 19 (10.2) 253 (13.1) 0.26
Cardiac embolism 67 (35.8) 557 (28.7) 0.042
Small vessel disease 7 (3.7) 277 (14.3) <0.001
Other cause 6 (3.2) 61 (3.2) 0.97
Unknown cause 88 (47.1) 783 (40.4) 0.084
Prior cerebral infarction 34 (18.2) 297 (15.3) 0.30
Myocardial infarction 25 (13.4) 251 (13.0) 0.89
Angina pectoris 20 (10.8) 216 (11.2) 0.86
Hypertension 105 (56.5) 989 (51.3) 0.18
Diabetes mellitus 29 (15.6) 272 (14.2) 0.60
Atrial fibrillation 66 (35.3) 481 (24.8) 0.002
Smoking 48 (27.9) 504 (27.3) 0.86
NIHSS* score on
admittance (SD)
6.9 (7.5) 4.9 (5.8) <0.001
Symptomatic ICA stenosis 41 (27.5) 283 (19.1) 0.014
Asymptomatic ICA stenosis 24 (16.2) 154 (10.5) 0.036
Lacunar infarctions 29 (15.5) 506 (26.1) 0.001
None-lacunar infarctions 158 (84.5) 1432 (73.9)
Old infarcts on MRI 72 (38.5) 630 (32.5) 0.098
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Figure 1. Relative frequencies of acute infarction in one (0)
versus more than one (1) arterial territory according to age
Table 2 Logistic regression with acute infarction in more than one arterial
territory versus one territory as dependent variable
Odds ratio 95% confidence interval P-value
Male 0.76 0.54–1.1 0.13
Age 1.00 1.00–1.02 0.31
Symptomatic ICA* stenosis 1.9 1.2–2.8 0.003
Cardiac embolism 1.5 1.1–2.3 0.025
*ICA, internal carotid artery.
Table 3 Mortality rates 7 days after stroke onset for different subtypes
compared to all other subtypes of stroke
No. of deaths P-value OR
Cardioembolism 44 (4.9) 0.001 2.085
Atherosclerosis 4 (1.3) 0.034 0.352
Small vessel disease 0 (0) <0.001 1
Unknown 33 (3.1) 0.78 0.940
Atrial fibrillation 45 (5.7) <0.001
MACI* 2 (1.1) 0.60
*MACI, Multiple Acute Cerebral Infarcts.
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Among 34 patients with MACI and unknown
etiology according to the TOAST criteria, CE
was considered probable due to MACI in three
arterial territories, supraventricular tachycardia,
palpitations likely to represent atrial fibrillation,
left bundle branch block, and no ICA stenosis.
We did not have data on the presence or not
of fetal posterior cerebral artery. We therefore
did subanalysis excluding 16 patients with DWI
lesions in both the anterior circulation and the
posterior circulation limited to the supply of the
posterior cerebral artery (temporal lobe, occipital
lobe, and thalamus). These analyses still showed
MACI to be associated with atrial fibrillation
(P = 0.002) and CE (P = 0.042).
Discussion
We confirm that acute cerebral infarcts in more
than one arterial territory are associated with CE.
Although intuitively not surprising, some studies
have been conflicting. Two South Korean studies
including 685 and 329 patients did not find an
association with CE (21, 22). Nevertheless, it
should be emphasized that the incidence of CE is
lower in South Korea (23). We should also con-
sider racial differences in the distribution of
extracranial and intracranial stenotic lesions
which can influence results of Asian studies.
There is higher prevalence of intracranial arterial
disease in Asians in contrast to Caucasians where
the atherosclerosis of the larger extracranial arter-
ies is more prevalent (24).
There are few studies regarding the etiology
standing behind small multiple lacunar infarcts
sometimes referred as a subtype of MACI (4).
One prospective study concluded that embolic
mechanisms were not a likely explanation for the
occurrence of multiple acute lacunar infarcts in
most patients, because definite embolic source
was found only in one patient of 10 patients with
MACI. Diffuse cerebral microvascular abnormal-
ities such as atherosclerosis or lipohyalinosis were
suggested as probable causes (25). According to
our results, small vessel disease causes only 3.7%
of all MACI. One possible explanation is that
lacunar infarctions sometime occur temporally
close. Another possibility is that some lacunar
infarctions are caused by CE or large-artery
atherosclerosis and not small vessel disease.
Takahashi et al. (2) reported that multiple lacu-
nar infarcts are more likely caused by CE and
large-artery atherosclerosis in accordance with
the present study.
We found acute cerebral infarcts in more than
one arterial territory in 8.8% of the patients. This
is similar to two recent studies (9.8 and 9.7%)
(7, 21). Other studies have reported higher fre-
quencies, but different inclusion criteria make the
comparison difficult (7). Many studies have
included patients with several DWI lesions in the
same arterial territory. However, these lesions are
probably caused by one thrombus or emboli
undergoing early fragmentation in most patients
(10). In our opinion, the mechanisms behind mul-
tiple DWI lesions in one arterial territory and
multiple DWI lesions in more than one arterial
territory should be analyzed separately as they
may be different in most cases.
On multivariate analyses, we found that mul-
tiple DWI lesions in more than one arterial ter-
ritory were associated with symptomatic ICA
stenosis independent of CE. Whether the cause
of symptomatic ICA stenosis including occlu-
sion is due to CE or large-artery disease (in-
cluding atherosclerosis) is sometimes difficult to
determine. Some studies have been unable to
differ between large-artery atherosclerosis and
CE as to association with acute infarcts in
more than one arterial territory, and this needs
more explorations in the future studies (21).
Clinical presentation of stroke and medical his-
tory can possibly help in distinguishing between
CE and other subtypes of stroke. The presence
of certain predictive factors such as sudden
onset of stroke to maximal deficit up to 5 min,
decreased level of consciousness at onset, spec-
tacular shrinking deficit syndrome, Wernicke/
global aphasia without hemiparesis, Wallen-
berg’s syndrome, valvular heart disease, and
onset of symptoms after a Valsalva-provoking
activity predict CE origin. In contrast, subacute
onset of stroke, chronic obstructive pulmonary
disease, hyperlipidemia, hypertension, TIA,
ischemic heart disease, and DM are potential
predictors of large atherosclerosis source of
MACI. In addition, lacunar stroke signs exclude
CE origin in most cases (26, 27).
Anatomical variations of cerebral arteries
should be also considered. PCA originates directly
from the ICA in up to 25%, which represents the
fetal type. Due to this anatomic variant, ICA dis-
ease may cause MACI in both the anterior and
posterior circulation simultaneously (22). Another
variation can possibly occur, unpaired ACA also
called azygos artery supplying both hemispheres.
The incidence of azygos ACA ranges from 0 to
5%, and its occlusion can result in bilateral infarct
(28). Furthermore, we have to consider the cross-
flow mechanism when single carotid artery lesion
can cause bihemispheric infarcts via intracranial
cross-flow through the anterior communicating
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artery (5). Vascular imaging of the cerebral vessels
is therefore necessary.
Interestingly, among patients with unknown eti-
ology according to the TOAST criteria, CE was
considered possible in a substantial fraction. This
suggests that the TOAST criteria fail to diagnose
CE in many patients with infarcts in more than
one arterial territory even after extensive investiga-
tions. Anticoagulation is highly effective for the
prevention of recurrent cerebral infarcts among
patients with atrial fibrillation (29). Compatible
with others (27), mortality among our patients
indicates that atrial fibrillation is associated with
severe stroke (Table 3). Our findings suggest that
anticoagulation should be considered among
patients with MACI and unknown etiology.
Strengths of our study include prospective
design, high frequency of MRI investigations, and
a large number of patients. However, there are
some limitations. Some patients did not undergo
full investigations and we probably underdiag-
nosed atrial fibrillation because we did not per-
form long-term ECG monitoring. A recent study
showed that long-term ECG monitoring with
insertable cardiac monitor is superior to conven-
tional follow-up for detecting atrial fibrillation at 6
and 12 months after cryptogenic cerebral infrac-
tion (30). More extensive investigations might have
disclosed the etiology among more patients. In
conclusion, acute cerebral infarcts in more than
one arterial territory occur among almost 10% of
the patients and are associated with CE.
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